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SUMMARY AND HIGHLIGHTS OF FINAL REPORT
The Predictive Studies VI Program consisted of two related
areas of research activity, integrated in design and performance,
that were each based on an ongoing analysis of human organ oxygen
tolerance data obtained from the continuous oxygen exposures of
the prior Predictive Studies V Program. The two research areas
effectively blended broad investigation of systematically varied
intermittent exposure patterns in animals with very selective
evaluation of specific exposure patterns in man.
OPTIMIZATION OF OXYGEN TOLERANCE EXTENSION IN ANIMALS
in order to determine rates of recovery from different
degrees of oxygen poisoning, oxygen exposure periods of 20, 60,
or 120 min were systematically alternated with a constant
normoxic interval whose duration was also varied systematically
in different exposures. Durations of normoxic intervals were
selected to provide the same hyperoxic:normoxic ratios for each
of the three oxygen exposure periods. This was done to determine
whether the toxic events accumulated over a relatively long
oxygen exposure (120 min) reversed on return to normoxia at the
same rate as those that accumulated during shorter oxygen
exposures (60 or 20 min).
Intact animal responses to the selected patterns of
intermittent exposure were determined at oxygen pressures of 1.5,
2.0, and 4.0 ATA. This range of oxygen pressures allowed
comparison of results obtained at 1.5 and 2.0 ATA, where effects
of pulmonary oxygen toxicity were not influenced by concurrent
convulsions, with comparable data obtained at 4.0 ATA, where
there were prominent interactions between pulmonary and central
nervous system effects of oxygen toxicity.
Rates of recovery from oxyqen poisoninq durinq intermittent
exposure. Overall analysis of the data obtained at all three
oxygen pressures revealed a high degree of internal consistency.
With only a few exceptions, median survival time increased
linearly at each pressure as the duration of the normoxic
recovery interval was lengthened while holding the oxygen
exposure period constant. Comparison of the slopes of the curves
for each oxygen exposure period at each pressure revealed that
recovery occurred most rapidly after the 20-min oxygen periods
and least rapidly after the 120-min periods. It also indicated
that rate of recovery for a given oxygen exposure period occurred
more rapidly at a lower oxygen pressure. Although these
relationships were anticipated qualitatively, the consistency of
the data provided an unequivocal, quantitative description of the
rate of recovery under each set of experimental conditions.
Intermittent exposure patterns with the same oxyqen:normoxic
_atio. Analysis of survival time responses to different
-i-
intermittent exposure patterns whose oxygen and normoxic periods
have the same ratio (e.g. 20:5 and 60:15 both have a 4:1 ratio)
showed that, within limits, similar results were obtained at the
same oxygen pressure. During intermittent exposures at oxygen
pressures of 4.0 and 2.0 ATA, this generalization did not apply
to patterns with 120-min oxygen periods (presumably due to the
occurrence of toxic events that were not readily reversed during
the subsequent normoxic revovery interval) or with 5-min normoxic
intervals (presumably too short a time for adequate recovery).
Operational application of the principle that similar extensions
of oxygen tolerance can be obtained with intermittent exposure
patterns whose oxygen and normoxic periods have the same ratio
will provide an empirical basis for selection of equally
effective intermittent exposure patterns, within appropriate
limits, to provide the shortest possible normoxic interval or the
longest possible oxygen exposure period.
Relevance of animal data to oxyqen tolerance extension in
man. Quantitative relationships defined in rats by empirical
curves that describe survival time extension by intermittent
oxygen exposure will not be directly applicable to man. However,
it is considered that the analytical methods used to derive the
descriptive curves from data obtained in rats will also be useful
for the analysis of human data obtained in early, reversible
stages of oxygen poisoning over an appropriate range of oxygen
pressures and intermittent exposure patterns. Although the
number of human intermittent oxygen exposures will necessarily be
much more selective and limited than was possible in rats, the
volume of pathophysiological information obtained from each
exposure will be immensely greater. The inherently limited
survival time data will be replaced by quantitative measurements
of oxygen effects on multiple organ systems and functions. The
rat data should also provide guidelines relevant to the
determination of optimum durations for the alternating oxygen
periods and normoxic intervals that, with appropriate
adjustment, should aid in the development of optimum patterns of
intermittent oxygen exposure for extension of organ-specific
oxygen tolerance in man.
EXTENSION OF OXYGEN TOLERANCE IN MAN
Orqan Specific Responses to Intermittent Exposure on a 60:15
Oxyqen:Normoxic Pattern at 2.0 ATA
Of the eight subjects who were exposed intermittently to
oxygen at 2.0 ATA on the 60:15 oxygen:normoxic pattern, primary
emphasis was placed on statistical analysis and interpretation of
average data for the six individuals who were exposed for 11.4 to
15.0 oxygen hours (mean 13.6 hours) and developed objective
visual and pulmonary manifestations of oxygen toxicity. In
agreement with the results of the previous continuous oxygen
exposures of Predictive Studies V, the eye and the lung were the
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primary targets of oxygen toxicity during intermittent oxygen
exposure at 2.0 ATA.
Effects on visual function. With few exceptions, the
effects of intermittent oxygen exposure at 2.0 ATA on visual
function were qualitatively similar to the effects observed
previously in the continuous oxygen exposures of Predictive
Studies V. Visual acuity, nearpoint accommodation, and pupil
diameter were not detectably affected by intermittent oxygen
exposure at 2.0 ATA. In contrast to the previous observation of
no change during and after continuous oxygen exposure at 2.0 ATA,
however, latency of the visual evoked cortical response was
significantly increased at the end of intermittent oxygen
exposure by an average value of 5.79 milliseconds (5.1%). It is
possible that this small, isolated change in visual evoked
cortical response was induced by fatigue rather than any specific
effect of oxygen toxicity.
During intermittent exposure to oxygen at 2.0 ATA, as in the
previous continuous exposures, peripheral visual field area and
the electroretinographic b-wave amplitude were the components of
visual function that were affected most consistently by oxygen
toxicity. In the six subjects who had the longest oxygen
exposures, average visual field area was significantly reduced by
13.9% at an exposure duration of ll.2 oxygen hours. It then
recovered partially to be reduced by 8.4% during the last hour of
exposure. An equal decrement during the early post-exposure
period was not statistically significant.
Electroretinographic responses (b-wave amplitude) to three
different light intensities, with only two exceptions, were
significantly reduced during the last hour of oxygen exposure and
were further reduced during the early post-exposure period.
Using an overall average of responses to all three light
intensities at each time of measurement, b-wave amplitude fell
progressively during intermittent oxygen exposure to a decrement
of 31.9% at 13.6 oxygen hours in six subjects, compared with the
previous observation of an average decrement of 39.4% in seven
subjects at 9.4 hours of continuous exposure in Predictive
Studies V.
Effects on pulmonary symptoms and function. An opportunity
to test in man the hypothesis that equivalent extensions of
oxygen tolerance are provided by intermittent hyperoxia patterns
whose oxygen:normoxic periods have the same ratio was provided by
the availability of the previous study of Hendricks et al (i) in
which the extension of pulmonary tolerance to oxygen exposure at
2.0 ATA on a 20:5 intermittent exposure pattern was measured in
normal men. Pulmonary responses to the 60:15 pattern of
intermittent exposure in the present Predictive Studies VI
Program were compared with the previously observed responses to
the 20:5 pattern, and average responses from both series of
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intermittent exposures were compared with results of the
continuous oxygen exposures of Predictive Studies V.
Rate of development of pulmonary oxygen poisoning during
either continuous or intermittent oxygen exposure at 2.0 ATA was
monitored subjectively at regular intervals by repeated surveys
of pulmonary symptoms. Each symptom survey included individual
ratings of cough, chest pain, chest tightness, and shortness of
breath as absent (0), mild (i+), moderate (2+), or severe (3+).
Overall average ratings that included all four symptoms and all
subjects in each group were calculated and plotted against
exposure duration for continuous and both intermittent exposures.
Results showed that both the 20:5 and 60:15 patterns of
intermittent oxygen exposure delayed the development of pulmonary
symptoms by degrees that were remarkably similar given the
subjective nature of the available information.
As an objective measure of toxic effects on pulmonary
function, average decrements in vital capacity were plotted
against exposure duration for continuous and intermittent
exposure. With respect to the curve for continuous exposure
(N=I6), both average curves for intermittent exposure reflected
increments in pulmonary oxygen tolerance, but the 20:5 exposure
pattern (N=5) appeared to be slightly more effective than the
60:15 pattern (N=6). Comparison of individual responses to the
60:15 intermittent exposure pattern with the average curves for
continuous exposure and the 20:5 intermittent exposure showed
that rates of decrease in vital capacity for four subjects on the
60:15 pattern were similar to the average curve for the 20:5
intermittent exposure pattern, while rates of vital capacity
decrement for the other two subjects were closer to the average
curve for continuous oxygen exposure. These results are
consistent with the interpretation that equivalent extensions of
pulmonary oxygen tolerance are provided by both the 60:15 and the
20:5 intermittent exposure patterns for most individuals, but
that an oxygen exposure period of 60 minutes is too long for a
minority of presumably more sensitive individuals.
Orqan Specific Responses to Intermittent Exposure on a 30:30
Oxyqen:Normoxic Pattern at 2.0 ATA
It was anticipated that the 30:30 intermittent exposure
pattern would extend oxygen tolerance significantly beyond that
provided by the 60:15 pattern, because it concurrently reduced
the toxic period by half and doubled the time allowed for
recovery in each successive cycle. An exposure duration of 15.0
oxygen hours, requiring a total of 29.5 continuous hours at 2.0
ATA, was selected as the maximum duration that was logistically
feasible. Of the six intermittent exposures that were completed
on the 30:30 pattern, four were continued for the planned
duration of 15.0 oxygen hours, and the other 2 were stopped at
13.0 hours. Although symptoms remained generally mild in most
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subjects, the first exposure was stopped at 13.0 oxygen hours
when the subject appeared to be developing prominent decrements
in visual and pulmonary function. The last exposure was also
stopped at 13.0 oxygen hours when the subject became extremely
anxious in association with chest tightness and shortness of
breath. Reversible decrements in visual and pulmonary function
were again the primary objective manifestations of oxygen
poisoning.
Effects on visual function. Average values for visual
evoked cortical responses, nearpoint accommodation, and pupil
diameter were similar before, during, and after intermittent
oxygen exposure. Except for a minor change from 20/25 to 20/30
in one subject, visual acuities were identical before, during,
and after exposure.
Changes in peripheral visual field area on the 30:30
intermittent exposure sequence were less consistent than
previously observed during either continuous exposure or
intermittent exposure on the 60:15 sequence. With respect to the
control measurement at the start of oxygen exposure, average
values were reduced by 5.5% at 8.0 oxygen hours, increased by
2.5% at I0.0 hours, reduced again by 6.4% at 13.0 hours, and
decreased by 5.3% at the end of oxygen exposure. With respect to
the pre-exposure control value, average visual field area was
increased by 3.1% during the early post-exposure period. None of
the observed changes in visual field area were statistically
significant.
Average changes in the electroretinographic b-wave amplitude
on the 30:30 sequence also differed qualitatively and
quantitatively from those found previously during either
continuous or intermittent exposure. With respect to the initial
control value, overall average responses to all three light
intensities for the six subjects on the 30:30 sequence were
essentially unchanged through 6.0 oxygen hours, fell abruptly to
an average decrement of 19.5% at 8.0 hours, and then recovered
progressively to reach an average decrement of only 3.3% at the
end of the intermittent exposure. None of these changes were
statistically significant. However, average responses to the
intermediate light intensity, which were qualitatively similar to
the overall average responses to all three intensities, were
significantly reduced by 26.8% at 8.0 oxygen hours. Progressive
recovery of b-wave amplitude during the second half of the
intermittent exposure on the 30:30 sequence contrasted sharply
with the concurrent progressive decrements observed during both
continuous oxygen exposure and intermittent exposure on the 60:15
sequence.
Effects on pulmonary symptoms and function. As expected,
pulmonary symptoms developed more slowly and were less severe on
the 30:30 sequence than for the previous intermittent exposures
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on the 60:15 sequence. Average symptom ratings at the end of
each of the three exposure series were 1.0 at 14.3 oxygen hours
on the 30:30 sequence, 2.0 at 13.6 oxygen hours on the 60:15
sequence, and 2.1 at 9.2 hours of continuous exposure.
Average vital capacity decrements for the six subjects
exposed intermittently on the 30:30 sequence initially were
nearly superimposed on the curve for continuous exposure to reach
an average decrement of 6.0% at 8.0 oxygen hours, then remained
essentially constant, crossing the curve for intermittent
exposure on the 60:15 sequence at ii.i hours to end at an average
decrement of 6.1% at 14.3 oxygen hours. Individual changes in
vital capacity at the end of oxygen exposure varied from -9.2% to
+1.4% of the initial control value. All of the changes in vital
capacity observed from 8.0 to 14.3 oxygen hours were
statistically significant. Although intermittent exposure on the
30:30 sequence allowed nearly 15 hours of oxygen breathing at 2.0
ATA with a relatively small change in vital capacity, as
predicted, the observation of vital capacity decrements that
initially exceeded those found previously for the 60:15 sequence
was not expected.
Interpretation of Observed Results
In agreement with results of the previous continuous oxygen
exposures at 2.0 ATA in Predictive Studies V, intermittent oxygen
exposure at 2.0 ATA on either the 60:15 or 30:30 oxygen:normoxic
sequence had little or no effect on brain electrical activity,
auditory and vestibular function, mental performance, and
psychomotor function. The most prominent toxic effects of
intermittent oxygen exposure at 2.0 ATA, again in agreement with
the effects of continuous exposure, were manifested as
significant alterations in specific aspects of visual function
(retinal electrical activity and peripheral vision) and in
several indices of pulmonary function.
With respect to the 60:15 oxygen:normoxic sequence, the
30:30 sequence halved the toxic oxygen period and doubled the
normoxic recovery interval. On the basis of general principles
of oxygen tolerance extension by intermittent exposure, and in
agreement with results of the 60:15 exposure sequence and the
extensive animal studies that were completed previously under
this Program, it was anticipated that visual and pulmonary
effects of oxygen toxicity would be undetectable or small in
magnitude throughout the 15.0 oxygen exposure hours that were
planned for the 30:30 sequence (total exposure duration of 29.5
hours). It was therefore suprising when both ERG b-wave
amplitude and vital capacity decreased initially at faster rates
than those found during the previously completed 60:15 exposure
sequence.
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Although the biochemical mechanisms responsible for
extension of oxygen tolerance by systematic alternation of oxygen
and normoxic exposure periods are not known, it is likely that
partial reversals of toxic effects during the normoxic recovery
periods play a major role. The observation that initial
decrements in ERG b-wave amplitude and vital capacity were
stabilized or partially reversed during continued intermittent
oxygen exposure on the 30:30 sequence indicates that during the
final hours of exposure the degree of recovery that occurred
during each normoxic interval must have equalled or exceeded the
cumulative toxic effects caused by the preceding oxygen period
for both visual and pulmonary manifestations of oxygen toxicity.
These apparently enhanced capacities for recovery from oxygen
poisoning were not evident during the first 8 to 10 hours of
exposure, when the degrees of visual and pulmonary oxygen
tolerance extension provided by the 60:15 exposure sequence were
overtly equal to or exceeded those provided by the 30:30
sequence.
Our results appear to indicate that the 60:15 sequence
afforded greater protection of oxygen tolerance than the 30:30
sequence during the initial hours of intermittent exposure, but
eventually became overwhelmed as the exposure continued. On the
other hand, the 30:30 sequence was relatively ineffective
initially, but then became sufficiently effective to stabilize or
reverse earlier decrements in both visual and pulmonary function
during the final hours of intermittent exposure. It is now well
established that exposure to hyperoxia increases the rates of
production of active species that are concurrently opposed by a
variety of antioxidant defenses. At a sufficiently high oxygen
pressure and/or for a sufficiently prolonged duration of
exposure, oxidant damage to cells and tissues occurs when
antioxidant defenses are overwhelmed. Periodic interruption of
oxygen exposure by restoration of normoxia should allow
antioxidant defenses to be maintained or possibly even enhanced.
One possible interpretation of our results can be based on
the hypothesis that extension of oxygen tolerance by intermittent
exposure depends not only upon cyclical periods of recovery from
oxygen poisoning, but also involves the concurrent augmentation
of antioxidant defenses or some other means of oxygen tolerance
enhancement. Previous animal studies have shown that antioxidant
defenses can be enhanced by sufficiently prolonged exposure to
toxic, sublethal levels of hyperoxia. It is possible that the
60:15 intermittent exposure pattern, by virtue of an inherently
greater level of toxicity, initiated the enhancement of
antioxidant defenses at an earlier time than the 30:30 pattern,
but was unable to sustain the level of production required for
continued protection. If the proposed hypothesis can be
confirmed, it may be possible to increase the benefits of
intermittent exposure by selecting appropriate patterns for
different parts of a prolonged exposure, or by basing the choice
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of a single pattern on the expected duration of intermittent
exposure.
Operational Relevance of Observed Results
Optimization of oxygen tolerance extension by intermittent
hyperoxic exposure will provide prominent and permanent
enhancement of diving operations, decompression methods, and
hyperoxygenation therapy. The research results are relevant to
both procedure and probability of success in all forms of diving
and decompression sickness therapy. Extension of CNS (visual)
and pulmonary oxygen tolerance to increased oxygen pressures
relates specifically and critically to both safety and
operational effectiveness in underwater operations, as well as
to improvement in therapy of gas lesion diseases. Although
extension of oxygen tolerance by intermittent exposure has been
studied only at rest to date, concurrent studies indicate that
the adverse effects of exercise on oxygen tolerance may be
avoided by preventing the hypercapnia and associated increments
in brain blood flow and oxygen dose that occur during oxygen
breathing at increased ambient pressures. Validation of this
working hypothesis will provide a basis for extension of oxygen
tolerance during exercise as well as at rest.
Our results show that both visual and pulmonary oxygen
tolerance can be extended significantly at 2.0 ATA by systematic
alternation of oxygen and normoxic exposure periods. They also
show clearly for the first time in man or in animals that early
toxic effects on the eye and lung can be stabilized or reversed
at least partially during continued intermittent exposure with an
appropriate combination of oxygen exposure and normoxic recovery
periods. The extents to which such reversals will occur at other
oxygen pressures and with other effects of oxygen toxicity remain
to be determined. Elucidation of the mechanisms for such
responses should provide information that can be widely exploited
in the development of more effective means for extension of
oxygen tolerance than those that are now available.
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INTRODUCTION TO BODY OF FINAL REPORT
The toxicity of oxygen is the primary factor limiting
effectiveness and safety in essentially all forms of diving.
Oxygen is the vital force in metabolism, but at the same time it
exerts toxic effects upon many of the critical life processes it
sustains. Even in natural atmospheres, the continuous generation
of oxygen free radicals produces destructive effects upon
enzymes, metabolic and membrane functions, and other biological
processes. Intrinsic antioxidant mechanisms normally scavenge
these free radicals, preventing gross cumulative damage.
However, as high oxygen pressures are used in diving, in
decompression, in treatment of decompression sicknesses, and in
hyperbaric therapy generally, the intrinsic antioxidant defense
mechanisms are overwhelmed, and evident oxygen poisoning can
develop. This can occur whether the high respired oxygen
pressure is provided as pure oxygen, as air, or in mixtures of
oxygen with helium or nitrogen as the inert carrier (or diluent)
gas. These toxic actions of hyperoxia must, at sufficient
pressure and duration of continuous exposure, be considered
capable of disrupting or destroying the vital processes of any
human cell.
Although oxygen must be considered to have universally toxic
properties with effects upon multiple chemical reactions, cells,
tissues, and organs, the best recognized limiting expressions of
oxygen poisoning in man are pulmonary symptoms and functional
degradations, and the central nervous system electrical
disruptions which produce generalized convulsions and
unconsciousness (2,3). These overt and readily recognizable
effects are not to be considered indicative of higher
"sensitivity" of brain cortex and lung to oxygen poisoning. They
simply represent grossly obvious effects with particular hazard
in underwater operations (4). In the prior Predictive Studies V
Program, an intensive investigation for other important but less
evident limiting forms of oxygen poisoning was carried out, and
preliminary results have been reported (5-8).
Influence of pressure and duration of hyperoxic exposure.
The toxic chemical effects of high oxygen pressures,
simultaneously exerted upon and inactivating multiple
intracellular and membrane enzyme systems, increase progressively
in degree (severity) as duration of oxygen exposure lengthens.
The rates of enzyme inactivation, with consequent failure of cell
and organ function, are speeded progressively as the oxygen
partial pressure of an exposure is increased. If all cells and
enzymes were both (a) equally sensitive to oxygen toxicity, and
(b) exposed at their locations in the body to the same partial
pressures of oxygen, prediction of tolerance to continuous oxygen
exposure would be relatively simple. However, each enzyme system
has its own sensitivity to oxygen poisoning. In addition, the
same enzyme system in different cell forms (brain, retina, lung,
-9-
kidney) has a different intracellular chemical environment and
even a different level of exposure to oxygen (3). Finally, the
enzymatic composition of cells in different vital organs is not
uniform. For all these reasons, the detectable consequences of
cellular oxygen poisoning are grossly different, function-by-
function (lung, brain, eye, muscle, ear, heart). Rates of onset
and recovery must also be considered grossly different, function-
by-function (3).
Practical use of oxygen at toxic high pressures. In spite
of its toxicity, oxygen at high pressures can be safely and
effectively used in diving and therapy. As with many drugs, an
adverse effect of oxygen does not become disturbing immediately,
and mild effects disappear when oxygen use is discontinued. The
safe periods for practical use of oxygen breathing are not
technically to be considered "Latent Periods", in spite of long
use of this term. Rather these are periods in which the degree
of toxic action is so small that it produces no symptoms or other
significant effects. Since mild effects develop slowly and
disappear when oxygen use is discontinued, repeated daily (or
more frequently) exposure to moderate hyperoxia is practical in
diving as well as in therapy. Rather, initial exposures can be
considered to represent a useful period of slowly progressing,
asymptomatic changes from which recovery can be prompt and
complete. The practical use of high oxygen pressures in diving
is based upon the inconsequential influences of oxygen during
initial periods of exposure. Extending this initial period of
tolerable or inconsequential toxicity will provide large
extensions of diving capability.
Defining human organ tolerance to continuous oxygen
exposure. The previous collaborative Predictive Studies V
Program was performed to determine the rates of development and
recovery in oxygen poisoning produced by uninterrupted oxygen
breathing over essentially the full range of oxygen exposure
useful in diving and hyperbaric therapy. This multiyear,
multidisciplinary Program investigated measurable physiologic and
toxic effects of oxygen upon selected organ and tissue functions
at 0.2, 1.5, 2.0, 2.5, and 3.0 ATA of inspired oxygen. This
Program represented the first systematic investigation of human
pulmonary oxygen poisoning at oxygen pressures greater than 2.0
ATA (5-8). It represented the only definitive investigation at
pressures greater than 1.0 ATA of oxygen poisoning effects in
other human organ systems and tissues, including brain, heart,
liver, kidney, skeletal muscle, and endocrine organs.
This extensive investigation of specific organ oxygen
tolerance, which followed over a decade of prior investigations
in animals and tissues to assure adequacy of scope and safety in
human experiment, has provided essential guidance for continuous
hyperoxic exposures in various diving and therapy situations.
The results obtained will be of permanent usefulness in defining
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the maximum capability for continuous oxygen exposure. This
investigation additionally serves as the required baseline for
the present Predictive Studies VI Program emphasis on optimal
extensions of human organ oxygen tolerance through use of
programmed interruptions of oxygen exposure over a useful range
of high inspired oxygen pressures.
Oxygen tolerance extension by programmed interruption of
oxygen exposure. A key concept emphasized early in this
Institute's continuing Oxygen Research Program is that, following
a toxic exposure to hyperoxia, a sufficient interval of normoxia
will allow for recovery and permit useful hyperoxic exposure
again (9,10). The duration of the recovery interval required
will depend upon the rate of onset, nature, and degree of induced
poisoning (and hence upon the rate of recovery). By systematic
investigation of rates of poisoning of different functions or
systems, at different oxygen exposure pressures, with tracking as
practical of the rates of recovery, it should be possible to
define (a) tolerance of critical functions to oxygen, and (b)
optimal programs of intermittent oxygen exposure, allowing
maximum effective use of oxygen at various pressures important to
therapy and undersea operations.
_teaation of animal and human investiqation of oxygen
tolerance extension. Although oxygen tolerance data obtained in
the rat cannot be applied quantitatively to man, it can provide
valuable guidelines for the selection of intermittent exposure
patterns to be evaluated in man. Attempts to determine optimum
intermittent exposure patterns solely in man would not only be
prohibitively expensive, but it would also involve unacceptable
risk of the occurrence of unexpected forms or degrees of oxygen
poisoning. The ultimate objective of oxygen tolerance extension
in man can be reached most effectively and safely by parallel
design and concurrent performance of both animal and human
investigation, thereby maximizing the opportunity for integration
of findings.
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METHODS
The Predictive Studies VI Program consisted of two related
areas of research activity, integrated in design and performance,
that were each based on an ongoing analysis of human organ oxygen
tolerance data obtained from the continuous oxygen exposures of
the prior Predictive Studies V Program. The two research areas
effectively blended broad investigation of systematically varied
intermittent exposure patterns in animals with very selective
evaluation of specific exposure patterns in man.
OPTIMIZATION OF OXYGEN TOLERANCE EXTENSION IN ANIMALS
In order to determine rates of recovery from different
degrees of oxygen poisoning, oxygen exposure periods of 20, 60,
or 120 min were systematically alternated with a constant
normoxic interval whose duration was also varied systematically
in different exposures. Durations of normoxic intervals were
selected to provide the same hyperoxic:normoxic ratios for each
of the three oxygen exposure periods. This was done to determine
whether the toxic events accumulated over a relatively long
oxygen exposure (120 min) reversed on return to normoxia at the
same rate as those that accumulated during shorter oxygen
exposures (60 or 20 min).
Durations of the oxygen periods and normoxic intervals for
intermittent exposure patterns that have been studied at 1.5,
2.0, and 4.0 ATA are shown in Appendix Table i. The selected
range of oxygen pressures allows comparison of results obtained
at 1.5 and 2.0 ATA, where effects of pulmonary oxygen toxicity
are not influenced by concurrent convulsions, with comparable
data obtained at 4.0 ATA, where there are prominent interactions
between pulmonary and central nervous system effects of oxygen
toxicity.
Exposure Conditions
For each intermittent pattern, a group of 20 rats, housed
individually in wire and plexiglass cages, was exposed in a steel
hyperbaric chamber with large viewports. Chamber concentrations
of oxygen and carbon dioxide were monitored continuously. During
oxygen periods, oxygen concentration was maintained at 99-100%.
Carbon dioxide concentrations were negligible during both oxygen
and normoxic periods. Ambient temperature was maintained within
a range of 22-25 °C. High gas flow rates were used at the start
of each oxygen or normoxic period to provide a 98% change of
inspired gas within 90 sec.
Animals
Male, specific pathogen-free, Charles River CD rats
maintained on Ziegler rat and mouse diet were used in these
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exposures. Average weights of the different exposure groups
ranged from about 300 to 400 grams with an overall average of
about 350 grams.
Oxygen Tolerance Indices in the Rat
Survival time. Elapsed oxygen time prior to cessation of
breathing was determined by 24-hour monitoring of all 20 rats in
each intermittent oxygen exposure. Although it is recognized
that many interacting factors determine the lethal duration of
exposure to any toxic oxygen pressure, survival time in a
sufficiently large animal population is an important general
index of oxygen tolerance, as it is for other toxic substances.
At oxygen pressures of 1.5 and 2.0 ATA, pulmonary oxygen
poisoning occurs in the absence of convulsions, while at 4.0 ATA
there are prominent interactions between pulmonary effects of
oxygen toxicity and the violent sympathetic activity associated
with convulsions.
Convulsion time. The elapsed oxygen time before initial
onset of seizures is also affected by many variables other than
inspired oxygen pressure. During continuous or intermittent
oxygen exposures at 4.0 ATA, however, onset of convulsions is a
definite and usually an early manifestation of central nervous
system oxygen poisoning.
Oraan specific indices of oxygen tolerance. It is highly
desirable to supplement data obtained from intact animals and man
with information describing the state of several confirmed or
potential organ-specific indices of oxygen tolerance in different
degrees of oxygen poisoning. However, broad investigation of
biochemical and histopathologic alterations in several critical
organs during both continuous and intermittent oxygen exposures
will be extremely costly and will require several years to
complete. The high cost is determined primarily by the
requirement for extensive measurement in multiple tissues, at
multiple points of exposure and recovery, and in multiple
patterns of exposure. The required investigations are therefore
beyond the scope of this Predictive Studies VI Program.
EXTENSION OF OXYGEN TOLERANCE IN MAN
Organ specific responses to two different patterns of
intermittent oxygen exposure at 2.0 ATA were evaluated in man.
One pattern, which alternated 60-min oxygen exposure periods with
15-min normoxic recovery intervals, was evaluated to test the
hypothesis that equivalent extensions of oxygen tolerance are
provided by intermittent hyperoxia patterns whose oxygen:normoxic
periods have the same ratio. A special opportunity to evaluate
the ratio principle in man was provided by the availability of
the previous study by Hendricks et al (I) in which the extension
of pulmonary tolerance to oxygen exposure at 2.0 ATA on a 20:5
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intermittent exposure pattern was measured in normal men. The
second pattern of intermittent exposure, which alternated 30-
min oxygen periods with 30-min normoxic intervals, was selected
to complement the information obtained from the 60:15 pattern by
testing the hypothesis that prominent improvement of oxygen
tolerance extension in man could be obtained by reducing the
toxic period by half and concurrently doubling the recovery
interval.
Intermittent Exposure on the 60:15 Oxyqen:Normoxic Pattern
Each experiment required 2 days for the intermittent oxygen
exposure, preceded by a day of preparation, and followed by at
least 3 days of post-exposure measurements. The experiment
protocol for the 2 days of exposure is summarized in Appendix
Figure I. Much of the first day was required for subject
preparation and pre-exposure control measurements. The
intermittent oxygen exposure typically began about 1600 hours and
continued overnight to end before noon the next day.
The sequence of measurements performed during the first and
last hours of oxygen exposure is shown in Appendix Figure 2.
Each measurement of a subset that was performed repeatedly during
the intermittent oxygen exposure to monitor the onset and
progression of toxic effects is denoted by an asterisk. The pre
and post-exposure measurements included a comprehensive
evaluation of pulmonary function in addition to the parameters
measured during exposure.
Intermittent Exposure on the 30:30 Oxyqen:Normoxic Pattern
The experiment protocol for the 30:30 oxygen:normoxic
exposure pattern at 2.0 ATA is summarized in Appendix Figure 3.
After a 5 to 6-hour period of subject preparation and control
measurements, the intermittent oxygen exposure at 2.0 ATA was
started at about 1200 hours and continued overnight to end at
about 1800 hours on the next day. An additional 5-6 hours of
pre-exposure control measurements obtained on 2 previous days are
not shown on the graph. An exposure duration of 15 oxygen hours,
requiring a total of 30 continuous hours at 2.0 ATA, was selected
as the maximum duration that was logistically feasible.
Completion of the intermittent oxygen exposure at 2.0 ATA
was followed at 1.0 ATA by a 7 to 8-hour period of post-exposure
measurements that extended into the early morning hours of the
next day. After a few hours of sleep, the subject was awakened
at about 0800 hours for an additional 6-8 hours of post-exposure
measurements, followed by shorter measurement periods on
subsequent days. The total period of study for each subject on
this protocol required 5 consecutive days for pre-exposure,
exposure, and post-exposure measurements, with additional days
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for medical evaluation of the subject, training, and follow-up
measurements.
The sequence of measurements that were performed at the
start and end of the intermittent oxygen exposure is shown in
Appendix Figure 4. Each measurement denoted by an asterisk was
part of a subset that was repeated at designated intervals during
exposure to monitor the onset and progression of toxic effects.
The 30-min duration of the oxygen period made it necessary to
perform some of the measurements during the subsequent normoxic
interval. The pre and post-exposure evaluation included
ventilatory control measurements and a comprehensive evaluation
of pulmonary function in addition to the measurements shown in
Appendix Figure 4.
Subjects
Each subject received a comprehensive medical evaluation
which included a medical history and physical examination,
neuro-ophthalmologic evaluation, electrocardiogram,
electroencephalogram, electroretinogram, visual acuity and
fields, chest x-ray, urinalysis, and hematology profile.
Informed consent was obtained on 2 separate occasions prior to
oxygen-exercise exposure at 2.0 ATA. All procedures and
measurements were approved by the Human Studies Committee of the
University of Pennsylvania.
Gas Administration System
Oxygen from an external liquid source was piped into the
chamber, humidified, and conducted to a 30-1iter reservoir bag
from which it was inspired by the subject through 1.0-inch i.d.
corrugated plastic tubing. Normoxic gas (10.5% 02 in N2) was
piped from an external premixed cylinder to a second humidifier
and reservoir bag system inside the chamber. Transitions between
oxygen and normoxic gas were accomplished by connecting the
inside gas administration system to the appropriate reservoir bag
and squeezing the bag to flush all connecting tubing up to the
subject. Relative humidity of the inspired gas, measured at flow
rates of about l0 to 50 L/min with a Cole-Palmer Model 3309-60
Thermo-hygrometer, was about 80% at chamber temperature.
Throughout most of the exposure, oxygen or normoxic gas was
administered via a lightweight, plastic, non-rebreathing,
oronasal facemask with an inflatable seal (Vital Signs Inc.).
During the brief periods required to perform related visual
measurements, the subject wore a noseclip and breathed oxygen via
a mouthpiece, non-rebreathing assembly. Expired gas was
conducted by corrugated plastic tubing to an overboard dump
system, except when it was collected to measure gas exchange.
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Mask oxygen concentration was monitored continuously with an
Applied Electrochemistry Model SA-3 Electrochemical 02 Meter.
Mask FO 2 remained consistently above 0.98 except for occasional
periods of about i0 seconds when the mask seal was transiently
breached by subject movement. End-tidal carbon dioxide
concentration was monitored with a Datex Model CD-101 CO 2
Analyzer.
Central Nervous System Function
Electroencephaloqraphy. Twelve channels of EEG were
continuously recorded from 12 scalp electrodes onto a Grass Model
8-16 EEG machine and onto a magnetic tape recorder. A modified
INT 10-20 system was used for electrode placement.
Mental performance. Mental and psychomotor function were
evaluated at 1.0 ATA before and after each intermittent oxygen
exposure, and at the start and end of intermittent exposure at
2.0 ATA. Specific tests that were used included a visual digit
span test of short term memory ability, a key insertion test of
finger dexterity ability, an operations test of number facility
and general reasoning abilities, and a visual reaction time test
of response speed ability. This sequence of four consecutive
tests was administered and scored by computer over a 7-min period
as a component of the Institute-developed Performance Measurement
System (ii).
Visual Function
Electroretinoqraphy. The electroretinogram (ERG) was
obtained from the dark adapted (right) eye, using a Burian-Allen
electrode that rested on a soft contact lens to prevent corneal
abrasion. The retinal response was elicited by a 10-microsecond
flash stimulus from a Grass Model PS22 Photostimulator outside
the chamber. A specially modified (sealed and purged with
nitrogen) photoflash tube inside the chamber was mounted onto a
standard Ganzfeld apparatus. Visual stimuli consisted of three
different intensities of blue or white light and one intensity of
red light. The largest b-wave amplitude obtained in two or three
trials was recorded for each intensity.
After magnification by a Grass Model PSll Amplifier, the
electrical signal from the ERG electrode was recorded and stored
within the memory of a Hewlett-Packard Model 3561A Signal
Analyzer. Hard Copy of the ERG trace was obtained with a
Hewlett-Packard Model 2671-G Graphic Printer.
Perimetry. Peripheral visual field measurements were made
monocularly on the light adapted (left) eye with the right eye
patched. Perimetric fields were plotted every 30 ° on a
Rodenstock Projection Perimeter using the 1.12 mm test spot.
Field luminance of the hemisphere was fixed at 0.50 log mL,
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while luminance of the test spot was maintained at 2.0 log mL.
All external chamber lights were turned off during the period of
visual field measurement. Maintenance of proper fixation was
assured throughout each period of measurement by frequent
monitoring with the viewing device built into the perimeter. The
stimulus was presented randomly in any of the 12 selected field
locations, with each presentation being from the "not seen" to
the "seen" mode. Responses to two complete sets of presentations
were averaged for each visual field measurement.
Visual evoked cortical _esponses. The pattern reversal
visual evoked cortical response (VER) was obtained with a Medical
Systems Corporation Model Dll2 Pattern Reversal Stimulator
outside the chamber projecting onto a rear projection screen
inside the chamber via a viewport. The subject was seated with
his eye at a distance of one meter from the screen. The signal
from the scalp EEG electrodes (Fz/Oz) was magnified by a Grass
P511 Amplifier and sent to a Hewlett-Packard 3561A Signal
Analyzer for signal averaging and recording (2671-G Graphic
Printer).
Visual _cuitv. Central visual acuity was measured with the
test chart on a modified MacBeth illuminator stand. The subject
was seated in front of the chart with his eye position maintained
at a fixed distance of 35 cm from the chart surface by a
restraining device which rested on the bridge of his nose and
cheekbones. The chart was viewed under the illumination of the
MacBeth source which provided 0.95 log lux illuminance
(approximately equivalent to average daylight). Visual acuity of
the left eye was measured with the right eye patched.
Accommodation. The closest distance at which the subject
could accommodate was measured with a modified Adler Near-Point
Rule. A fine-letter target attached to a millimeter rule was
initially positioned to be in sharp focus for the left eye with
the right eye patched. It was then moved slowly toward the eye
while the subject actively accommodated to the decreasing
distance until blurring began at the near-point. Accommodative
near-point was measured as the average of at least 5 readings.
All trials were performed with chamber lights on full brightness.
_pilometrv. Diameter of the left pupil was estimated to
the nearest 0.5 mm by matching pupil size with a range of
similar test circles on a standard chart. This determination was
made with chamber lights on full brightness while the subject
looked directly at the light.
Ventilation and Gas Exchanqe
During oxygen breathing at 2.0 ATA, inspiratory flow and
pattern of ventilation were measured with a pneumotachygraph
(Fleisch #4) on the inspiratory side of the gas administration
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system. These measurements were supplemented with timed
collections of expired gas in a large weather balloon which was
then evacuated to 1.0 ATA for measurement of volume in a wet test
gasometer: Mean expired C09 concentration was also measured at
1.0 ATA wlth a Datex Model _D-101 Infrared CO 2 Analyzer.
Arterial Blood Gases
Arterial blood was sampled anaerobically into precision-
bored glass syringes by standard procedures. Analyses for pH,
PCO-, and PO were performed in duplicate with a Corning Model
165ZBlood Ga_ Analyzer electrode block especially adapted for use
inside the chamber. Blood gas and pH measurements at 1.0 ATA
were performed in duplicate with an Instrumentation Laboratory
Model 1304 Blood Gas Analyzer.
Body Temperature
Rectal temperature was recorded continuously. The
temperature sensor was a Yellow Springs 400 series probe with a
Model 46 thermistor thermometer and a range of 35 to 45°C.
Pulmonary Function
Automated flow volume loops inside and outside the chamber
were obtained with "dry sealed" spirometers (Ohio Medical
Products Models 827 and 840) and Vacumetrics Inc. software.
Carbon monoxide diffusing capacity of the lung was measured with
a W. E. Collins Inc. Modular Lung Analyzer. Airway resistance,
pulmonary compliance, and functional residual capacity were
measured using a W. E. Collins Inc. Body Plethysmograph.
Cardiovascular Function
Electrocardioqram. The ECG was monitored continuously on a
Siemens Corporation Model Sirecust 400 Clinical Monitor and
recorded onto magnetic tape and a Holter Monitor.
Cardiac output. Cardiac stroke volume was measured with the
aid of a Minnesota Impedance Cardiograph (Instrumentation For
Medicine Inc. Model 304A) whose output was recorded onto a
Honeywell Visicorder (906B) and onto magnetic tape. Cardiac
output was calculated as the product of heart rate and stroke
volume.
Blood pressure. Blood pressure was measured via an
indwelling arterial catheter using a disposable blood-pressure
transducer (Abbott Critical Care Systems) coupled to the Siemens
Patient Monitor. The pulse waveform was recorded onto a
Visicorder Oscillograph.
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Orthostatic maneuver. An orthostatic maneuver was obtained
at selected intervals by having the subject arise from the prone
position to the standing position in a rapid but controlled
maneuver. The ECG, beat-by-beat heart rate, blood pressure, and
cardiac stroke volume were simultaneously recorded onto the
Visicorder Oscillograph before, during, and after the orthostatic
maneuver.
Statistical Analysis
Means and standard deviations for each measurement parameter
and experimental condition are summarized in appendix data
tables. Average values include all subjects for whom data are
available. In some cases, it was not possible to obtain data for
all subjects in each condition. For statistical comparisons of
average values for different conditions, analyses across a range
of conditions were performed with data only from the same
subjects. All tests were made at the 5% level, with critical
values adjusted for multiple comparisons where required.
Analysis of variance techniques were applied to all data
obtained from measurements at regular intervals during
intermittent oxygen exposure. Paired t-tests were performed on
data obtained at 1.0 ATA before and after intermittent oxygen
exposure at 2.0 ATA, and on data obtained at the start and end of
the 2.0 ATA exposures.
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RESULTS AND DISCUSSION
ANIMAL STUDIES
Effects of Intermittent Oxygen Exposure on Survival Time at 4.0,
2.0, and 1.5 ATA
Survival times in groups of 20 rats exposed intermittently
to oxygen pressures of 4.0, 2.0, and 1.5 ATA are shown in
Appendix Figures 5, 6, and 7, respectively. Mortality curves for
oxygen periods of 20, 60, and 120 min, each combined with several
normoxic intervals, are shown for each pressure. Mortality
curves for groups of 20 or more rats exposed continuously to
oxygen at each pressure are shown as dashed lines. Survival
times for the intermittent exposures show cumulative oxygen time,
with no indication of the cumulative duration of normoxic
exposure. Results are described initially with respect to
intermittent patterns having the same oxygen period (20, 60, or
120 min), and later with respect to patterns having the same
oxygen:normoxic ratio.
Intermittent patterns with 20-min oxygen exposure periods.
Alternation of 5-min normoxic intervals with 20-min oxygen
exposure periods did not increase survival time at either 4.0 or
2.0 ATA (App. Figs. 5 and 6), but median survival time was
increased by 24% for the same pattern at 1.5 ATA (App. Fig. 7).
Doubling the normoxic interval to 10 min increased median
survival time by 46% at 4.0 ATA, 29% at 2.0 ATA, and 64% at 1.5
ATA. Again doubling the normoxic interval to 20 min produced
only a 56% increment in survival time at 4.0 ATA, but median
survival time at 2.0 ATA was more than doubled (+113%). The
20:20 oxygen:normoxic pattern was not evaluated at 1.5 ATA for
reasons that are given below.
Intermittent patterns with 60-min oxygen exposure periods.
Combination of 60-min oxygen periods with normoxic intervals of
15 and 30 min increased median survival time, respectively, by
32% and 47% at 4.0 ATA, 18% and 39% at 2.0 ATA, and 26% and 42%
at 1.5 ATA. The 60:60 oxygen:normoxic pattern, which was not
evaluated at 1.5 ATA, increased survival time by 62% and 100% at
4.0 and 2.0 ATA, respectively. When 60-min oxygen periods were
alternated with 180-min normoxic intervals at 4.0 ATA, survival
time increased by 121%, but the same exposure pattern at 2.0 ATA
allowed all 20 rats to tolerate 67 oxygen hours (3.7 x median
survival time for continuous exposure) over a total time of 11
days without a single death. Electron microscopy of the lungs
from 6 randomly selected rats revealed only minimal alterations
of pulmonary ultrastructural constituents.
Intermittent patterns with 120-min oxygen exposure periods.
When 120-min oxygen periods were alternated with 30-min normoxic
intervals at 4.0 ATA, survival times for many rats were actually
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shorter than those for continuous exposure. Evidently, the long
oxygen exposure periods at 4.0 ATA, with only 30-min recovery
periods, produced enough lung damage to cause fatal hypoxemia
upon return to a normoxic atmosphere. The same program at 2.0
and 1.5 ATA increased median survival time by 8% and 19%,
respectively. The 120:60 oxygen:normoxic pattern lengthened
survival time by 47%, 33%, and 41% at 4.0, 2.0, and 1.5 ATA,
respectively. When 120-min oxygen periods and normoxic
intervals were alternated at 4.0 and 2.0 ATA, survival time was
increased by 66-67%. At 1.5 ATA, however, the same intermittent
exposure pattern was continued for 60 oxygen hours without a
single death. The experiment was discontinued at this time,
because the rats did not appear to be in a preterminal state at
an exposure duration that already represented a 124% increment in
median survival time.
_ntermittent patterns with i:i oxyqen:normoxic ratios.
Relative increments in median survival times for the 20:20,
60:60, and 120:120 patterns at 4.0 ATA were 56%, 62%, and 66%,
respectively (Appendix Figure 5). Corresponding patterns at 2.0
ATA produced relative gains of 113%, 100%, and 67%, respectively
(Appendix Figure 6). The 20:20 and 60:60 patterns produced
similar results at each pressure, and both patterns were more
effective at 2.0 than at 4.0 ATA. Median survival time for the
120:120 pattern was at least equal to or slightly longer than
that for the other 2 patterns at 4.0 ATA, but was much shorter
than survival times for the other patterns at 2.0 ATA. The
reduced effectiveness of survival time extension by the 120:120
pattern at 2.0 ATA was most evident among the more resistant
rats.
In contrast to the 67% increment in survival time for the
120:120 pattern at 2.0 ATA, the same pattern at 1.5 ATA was
terminated with no deaths at 60 oxygen hours which represented a
124% increment in survival time (Appendix Figure 7). The 20:20
and 60:60 exposure patterns were not evaluated at 1.5 ATA,
because the results obtained at 2.0 ATA (Appendix Figure 6)
indicated that they would extend survival time even more than the
120:120 pattern.
Intermittent patterns with 2:1 oxyqen:normoxic ratios. All
3 intermittent exposure patterns whose oxygen:normoxic periods
have a 2:1 ratio produced relative increments in median survival
times of 46-47% at 4.0 ATA and 29-39% at 2.0 ATA (Appendix
Figures 5 and 6). A similar uniformity of response to all 3
patterns was not found at 1.5 ATA, where both the 60:30 and
120:60 patterns increased survival time by about 42%, but the
20:10 pattern produced a 64% increment (Appendix Figure 7). With
this single exception, the similarity of responses to the 20:10,
60:30, and 120:60 patterns suggests in principle that, within the
range that was evaluated, a wide variety of exposure patterns
with 2:1 ratios would provide similar extensions of survival
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time. Operational application of the same principle would
provide a means for selection of equally effective intermittent
exposure patterns, within an appropriate range, on the basis of
the shortest possible normoxic interval or the longest possible
oxygen exposure period.
Intermittent patterns with 4:1 oxyqen:normoxic ratios.
Responses to the intermittent exposure patterns with 4:1
oxygen:normoxic ratios at 4.0 and 2.0 ATA show that the 60:15
pattern provided the greatest extensions of median survival times
at both oxygen pressures, with 32% and 18% increments at 4.0 and
2.0 ATA, respectively (Appendix Figures 5 and 6). The 20:5
pattern did not increase survival time at either pressure, while
the 120:30 pattern decreased median survival time by 12% at 4.0
ATA and increased it by 8% at 2.0 ATA. The results at 4.0 and
2.0 ATA indicate that a 5-min normoxic interval is too short for
significant recovery, with respect to survival time, even after
an oxygen exposure of only 20 min. They also indicate that 120-
min oxygen exposure periods cause toxic changes that reverse less
completely, even when alternated with 30-min normoxic intervals,
than those caused by exposures of 60 min or less.
In marked contrast to the results obtained at 4.0 and 2.0
ATA, all 3 patterns with an oxygen:normoxic ratio of 4:1 produced
similar extensions of survival time at 1.5 ATA (Appendix Figure
7). Relative increments in median survival time, as compared
with that for continuous exposure, for the 20:5, 60:15, and
120:30 intermittent exposure patterns were 24%, 26%, and 19%,
respectively. These results indicate that significant recovery
from 20-min oxygen exposure periods at 1.5 ATA can occur with
normoxic intervals as short as 5 min, in contrast to the absence
of survival time extension for the 20:5 intermittent exposure
pattern at 2.0 and 4.0 ATA. Results obtained at 1.5 ATA also
show that 120-min oxygen exposure periods are not too long to
allow significant reversal of toxic effects during 30-min
normoxic recovery intervals. Both observations are consistent
with the fact that oxygen poisoning occurs more slowly at 1.5 ATA
than at higher oxygen pressures.
Summary and Interpretations of Animal Data
Relationships of survival time increments to normoxic
interval durations. Median survival times for all of the
intermittent exposure patterns that have been evaluated to date
are plotted against durations of the corresponding normoxic
intervals in Appendix Figure 8. Points are grouped by oxygen
pressure and duration of the oxygen exposure period for each
pressure. Lines drawn through the 9 different groups of points
indicate the rates at which survival time is lengthened by
progressively increasing the duration of normoxia while holding
the oxygen exposure constant at 20, 60, or 120 min. The slopes
of the lines should also reflect the relative rates at which
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toxic events are reversed upon termination of the corresponding
oxygen exposure.
Rates of recovery in relation to exposure patterns.
Comparison of the slopes in Appendix Figure 8 indicates that
recovery occurs most rapidly after the 20-min (short) oxygen
exposures and least rapidly after the 120-min (long) exposures.
It also indicates that rate of recovery for a given oxygen
exposure period occurs more rapidly at a lower oxygen pressure.
Although these relationships were anticipated qualitatively, the
data consistency affords a clear quantitative description of the
rate of recovery under each set of experimental conditions.
The slopes of the curves in Appendix Figure 8 can be used to
estimate empirically the effectiveness of selected intermittent
exposure patterns throughout the ranges of oxygen pressure and
exposure period that were evaluated. Numerical values of the 3
slopes for each oxygen pressure are listed in Appendix Table 2
and plotted on each side of Appendix Figure 9. On the left the
slopes of the curves at 1.5, 2.0, and 4.0 ATA are plotted on the
ordinate against duration of the corresponding oxygen exposure
period on the abscissa. On the right the slopes for 20-min, 60-
min, and 120-min oxygen exposure periods are plotted on the
ordinate against the corresponding oxygen pressure on the
abscissa. Both sets of curves describe smooth relationships that
would permit interpolations with a reasonable degree of accuracy.
As an example, interpolated values at 3.0 ATA on the right-side
curves are plotted on the left to provide a predicted curve for
3.0 ATA.
The empirical curves in Appendix Figure 9 are based on
extension of survival time in rats by intermittent oxygen
exposure at pressures of 1.5, 2.0, and 4.0 ATA. The quantitative
relationships defined by these curves will not be directly
applicable to man. However, the principles are, and it is
considered that the analytical methods used to derive the
descriptive curves from data obtained in rats will also be useful
for the analysis of human data obtained in early, reversible
stages of oxygen poisoning. Although the number of human
intermittent oxygen exposures will necessarily be much more
selective and limited than was possible in rats, the volume of
pathophysiological information obtained from each exposure will
be immensely greater. The inherently limited survival time data
will be replaced by quantitative measurements of oxygen effects
on multiple organ systems and functions. The rat data will also
provide guidelines relevant to the determination of optimum
durations for the alternating oxygen periods and normoxic
intervals that, with appropriate adjustment, will aid in the
development of optimum patterns of intermittent oxygen exposure
for extension of organ-specific oxygen tolerance in man.
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HUMAN STUDIES
EVALUATION OF ORGAN SPECIFIC RESPONSES TO INTERMITTENT EXPOSURE
ON A 60:15 OXYGEN:NORMOXIC PATTERN AT 2.0 ATA.
Of the 8 subjects who were studied on this pattern, one had
a claustrophobic reaction to breathing through a facemask in an
enclosed space, and his exposure was stopped at 7.0 oxygen hours.
Since this subject had a relatively short exposure with no
subjective or objective manifestations of oxygen poisoning at the
time of exposure termination, his measurements were not included
in the overall analysis of data. The intermittent exposure of
one other subject was stopped at 9.0 oxygen hours when he
experienced severe nausea. Although his data were included in
the average results reported for 7 subjects, primary emphasis was
placed on statistical analysis and interpretation of average data
for the 6 subjects who had longer exposures and developed
objective pulmonary and visual manifestations of oxygen toxicity.
Statistical analyses were performed on average data for fewer
than 6 subjects in some cases where measurements were incomplete
or technically flawed.
Exposure Duration and Symptoms
Duration of each intermittent oxygen exposure was expressed
in terms of cumulative oxygen hours for comparison with the
effects of the continuous exposures that were done previously in
other subjects as part of Predictive Studies V. Exposure
durations ranged from 9.0 to 15.0 hours for an overall average of
12.9 hours in 7 subjects. At regular intervals during exposure,
each subject reviewed a list of symptoms and rated each as absent
(0), mild (1+), moderate (2+), or severe (3+). Tolerable
duration of exposure was primarily limited by pulmonary symptoms
in 6 subjects who had a mean exposure duration of 13.6 oxygen
hours (range 11.4-15.0 hours) and by severe nausea in 1 subject
(9.0 hours). All but 1 of the 6 subjects who had severe
pulmonary symptoms also had severe nausea prior to or just after
the end of oxygen exposure. This was sometimes exacerbated in
association with vomiting during the early post-exposure period.
Effects on Brain Electrical Activity
Online inspection of electroencephalographic records during
intermittent oxygen exposure revealed no evident abnormalities of
brain electrical activity. Signs of incipient convulsions were
not expected during these exposures, and none were observed.
Detailed analysis of the electroencephalographic records has not
been completed.
Effects on Auditory-Vestibular Function
Auditory and vestibular functions were evaluated
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comprehensively in each subject under controlled laboratory
conditions before and after intermittent oxygen exposure at 2.0
ATA. The large volume of post-exposure measurements in
conjunction with the requirement for performing auditory-
vestibular measurements in a hospital laboratory during normal
business hours made it impractical to obtain these measurements
until about 24 hours after exposure termination. Although it is
possible that subtle toxic effects could have reversed completely
during this unavoidable delay, any functionally significant
residual effects would be detected.
Auditory and vestibular functions were well maintained after
the intermittent exposures. No significant shifts in hearing
thresholds were revealed by either conventional or extended high
frequency audiometry. Acoustic immittance data did not detect
alterations in middle ear function, and auditory brainstem
responses showed no abnormalities in neural transmission. Post-
exposure caloric responses were also normal.
Mental Performance and Psychomotor Function
Mental performance and psychomotor function were evaluated
in 7 subjects during air breathing at 1.0 ATA before and after
oxygen exposure and during oxygen breathing at 2.0 ATA at the
start and end of intermittent exposure. Individual and average
results are summarized in Appendix Table 3. Testing of manual
dexterity was technically satisfactory in only 4 of the 7
subjects.
Short term memory, manual dexterity, number facility, and
general reasoning ability were all well maintained during and
after intermittent oxygen exposure at 2.0 ATA. However, visual
reaction time was increased in 6 of 7 subjects at the end of
oxygen exposure with average values of 0.282 and 0.322 seconds at
the start and end of exposure, respectively. Measurements
obtained before and after oxygen exposure also reflected a slight
lengthening of reaction time in all 7 subjects with average
values of 0.283 and 0.336 seconds, respectively. Neither of
these changes were statistically significant. However, in the 6
subjects who had the longest intermittent oxygen exposures (11.4
to 15.0 oxygen hours), the 0.047-second increment (16.1%) in
visual reaction time observed at the end of oxygen exposure was
statistically significant. It is possible that this barely
detectable slowing of visual reaction time represented an effect
of fatigue rather than a specific effect of oxygen toxicity.
Effects on Visual Function
Measurements of visual function that were obtained before,
during, and after intermittent oxygen exposure at 2.0 ATA
included visual acuity, nearpoint accommodation, pupilometry,
visual evoked cortical responses, visual fields, and retinal
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electrical activity. All of these parameters were measured
during air breathing at 1.0 ATA before and after the intermittent
oxygen exposure and during the first and last hours of oxygen
exposure at 2.0 ATA. Visual field area and the electroretinogram
(ERG) b-wave amplitude were also measured at regular intervals
during intermittent oxygen exposure as primary indices of toxic
effects on visual function.
With few exceptions, the effects of intermittent oxygen
exposure at 2.0 ATA on visual function were qualitatively similar
to the effects observed previously in the continuous oxygen
exposures of Predictive Studies V (5,12). Average measurements
of visual responses to intermittent oxygen exposure are
summarized in Appendix Tables 4-6. Visual acuity, nearpoint
accommodation, and pupil diameter were not detectably affected by
intermittent oxygen exposure at 2.0 ATA (Appendix Table 4). In
contrast to previous observation of no change during and after
continuous oxygen exposure at 2.0 ATA, however, latency of the
visual evoked cortical response was significantly increased at
the end of intermittent oxygen exposure by an average value of
5.79 milliseconds (5.1%).
Average changes in visual field area during and after
intermittent oxygen exposure at 2.0 ATA are summarized in
Appendix Table 5. In the 6 subjects who had the longest oxygen
exposures, average visual field area was significantly reduced by
13.9% at an exposure duration 11.2 oxygen hours. It then
recovered partially to be reduced by 8.4% during the last hour of
exposure. An equal decrement during the early post-exposure
period was not statistically significant.
Electroretinographic responses (b-wave amplitude) to 3
different light intensities are summarized in Appendix Table 6.
With few exceptions, average retinal responses to all 3
intensities were significantly reduced during the last hour of
oxygen exposure and were further reduced during the early post-
exposure period. The only 2 values that were not significantly
reduced were the post-exposure response to the intermediate light
intensity (N=6) and the end-exposure response to the brightest
light flash (N=6). Average percent decrements for the 3 combined
light intensities in the 6 subjects who had the longest
intermittent oxygen exposures are shown in Appendix Figure i0
along with comparable average responses for 7 other subjects who
were previously exposed continuously to oxygen at 2.0 ATA in
Predictive Studies V.
The average ERG b-wave amplitude during continuous exposure
was not detectably altered for the first 4 hours and then
decreased nearly linearly to reach an average decrement of 39.4%
after 9.4 hours of exposure. During intermittent oxygen
exposure, average b-wave decrements of 8.2% at 5.4 oxygen hours,
8.5% at 9.4 oxygen hours, followed by a progressive decline to
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31.9% at 13.6 oxygen hours, define a curve that appears initially
to be superimposed on the curve for continuous exposure, then
shifts abruptly to the right to fall in parallel with the
continuous exposure curve.
Rate and Pattern of Pulmonary Ventilation
As potential indices of toxic effects on pulmonary
ventilation and ventilatory control, rate and pattern of
ventilation were measured before, during, and after intermittent
oxygen exposure at 2.0 ATA. Measurements of ventilation along
with rate of CO 2 elimination were obtained by collection of
expired gas during air breathlng at 1.0 ATA before and after
intermittent oxygen exposure and at regular intervals during the
2.0 ATA oxygen exposure. Average values obtained in all 7
subjects and in the 6 subjects who were exposed for 11.4 to 15.0
oxygen hours are summarized in Appendix Table 7. Average values
for fewer than 6 subjects are also indicated where complete data
are not available. Some of the average values for the various
combinations of subjects that are cited below are not included in
Appendix Table 7.
In the transition from breathing air at 1.0 ATA to breathing
oxygen at 2.0 ATA, expiratory minute volume increased
significantly from 6.78 to 9.77 L/min (N=5). This well defined
stimulatory effect of acute hyperoxia on ventilation is caused by
central accumulation of CO 2 secondary to an oxygen-induced
alteration in blood CO 2 transport (3,7). The same 5 subjects had
a decrease in expiratory minute volume from 11.18 to 8.47 L/min
during the reverse transition from oxygen breathing at 2.0 ATA to
air breathing at 1.0 ATA. The ventilatory changes observed at
the start and end of oxygen exposure were associated with
reciprocal changes in end-tidal PCO 2. Average PCO 2 (N=7)
decreased significantly from 40.8 mm Hg during air breathing at
1.0 ATA to 33.6 mm Hg at the start of the 2.0 ATA oxygen
exposure. In the reverse transition at the end of oxygen
exposure, end-tidal PCO 2 (N=6) increased from 30.8 to 36.2 mm Hg.
An increased frequency of breathing with a related reduction
in tidal volume was found near the end of prolonged, continuous
oxygen exposures at 1.5 or 2.0 ATA (7,13). Since this response
occurred concurrently with pulmonary symptoms of at least
moderate severity, it may have represented a conscious or reflex
effort to avoid chest pain by using a shallow, tachypneic
breathing pattern.
The data summarized in Appendix Table 7 indicate that
prolonged, intermittent oxygen exposure at 2.0 ATA provoked a
similar response. Average respiratory rate in the 6 subjects who
had the longest oxygen exposures increased significantly from
15.7 to 20.1 breaths/min at the start and end of oxygen exposure,
respectively. The associated reduction in tidal volume from
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0.56 to 0.51 L was not significant. Although the concurrent
change in expiratory minute volume from 9.54 to 11.17 L/min was
not statistically significant, the preceding value of ll.10 L/min
at 11.6 oxygen hours was significantly elevated by analysis of
variance. End-tidal PCO 2 also decreased significantly from 33.9
mm Hg at the start to 30.1 mm Hg at the end of oxygen exposure.
Effects on Pulmonary Function
Rate of development of pulmonary oxygen poisoning during
intermittent oxygen exposure at 2.0 ATA was monitored
subjectively at regular intervals by repeated surveys of
pulmonary symptoms. Each symptom survey included individual
ratings of cough, chest pain, chest tightness, and shortness of
breath as absent (0), mild (I+), moderate (2+), or severe (3+).
Average ratings of all 4 pulmonary symptoms were combined at each
exposure interval for the 6 subjects whose exposures were long
enough to reach pulmonary limits. These overall "pulmonary
symptom" ratings are plotted against exposure duration in
Appendix Figure ii to describe rate of development of pulmonary
symptoms during intermittent exposure at 2.0 ATA on a 60:15
oxygen:normoxic pattern. For comparison with this curve,
Appendix Figure ii also contains a similar curve obtained
previously in this laboratory for continuous oxygen exposure at
2.0 ATA (6,14) and a curve obtained by Hendricks et al (i) for
intermittent exposure at 2.0 ATA on a 20:5 oxygen:normoxic
pattern. Both patterns of intermittent oxygen exposure delay the
development of pulmonary symptoms by degrees that are remarkably
similar given the subjective nature of the available information.
Rate of decrease in vital capacity. Flow-volume loops were
performed at regular intervals during intermittent oxygen
exposure at 2.0 ATA to monitor toxic effects on pulmonary
mechanical function. Average values for selected lung volumes
and flow rates are summarized in Appendix Table 8. Of the lung
volumes and flow rates that can be obtained from a flow-volume
loop, vital capacity proved to be a useful index of pulmonary
oxygen poisoning during intermittent exposure (I), as it had
previously during continuous oxygen exposure (13). Average vital
capacity data for the 6 subjects who had the longest
intermittent exposures are plotted in Appendix Figure 12 along
with average curves obtained previously for continuous exposure
in this laboratory (14) and for intermittent exposure on a 20:5
pattern by Hendricks et al (i). Both curves for intermittent
exposure reflect increments in pulmonary oxygen tolerance, but
the 20:5 exposure pattern appears to be more effective.
Individual vital capacity data for the 6 subjects exposed
for ll.4 to 15.0 oxygen hours on the 60:15 intermittent exposure
pattern are superimposed on the curves for continuous oxygen
exposure and intermittent exposure on the 20:5 pattern in
Appendix Figure 13. The data show that rates of decrease in
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vital capacity for 4 subjects on the 60:15 pattern are similar to
the average curve for the 20:5 intermittent exposure pattern,
while rates of vital capacity decrement for the other 2 subjects
are closer to the average curve for continuous oxygen exposure.
These similarities are even more evident in Appendix Figure 14
where the average curve for the 4 subjects who had relatively
slow rates of decrease in vital capacity on the 60:15
intermittent exposure pattern is nearly superimposed on the
average curve for the 20:5 exposure pattern, while the average
curve for the other 2 subjects is much closer to the average
curve for continuous oxygen exposure.
post-exPosure evaluation of pulmonary function. In addition
to measuring lung volumes and flow rates at regular intervals
during intermittent oxygen exposure at 2.0 ATA, extensive
evaluations of pulmonary function were performed at 1.0 ATA
before and after the 2.0 ATA intermittent oxygen exposure.
Average results of these measurements are summarized in Appendix
Table 9. Average values are given for all 7 subjects and for the
6 subjects who had the longest oxygen exposures.
Separate measurements of vital capacity as part of a flow-
volume loop (FVC) or as an independently performed slowly
delivered exhalation (SVC) are in good agreement. Average FVC
and SVC decrements in the 6 subjects who reached pulmonary limits
of exposure are both 0.59 L (representing 11.3% and 11.1%,
respectively, of the corresponding control values). This
measurement, obtained about 3-4 hours post-exposure, reflects
partial recovery from the 14.7% decrement that was present at the
end of oxygen exposure (Appendix Figure 12). Concurrent
measurements of inspiratory capacity (IC) and expiratory reserve
volume (ERV) (Appendix Table 9) show that the vital capacity
decrement is contained within the inspiratory component of this
lung volume, in agreement with previous observations obtained
after continuous oxygen exposure at 2.0 ATA (13).
Lung expiratory function and compliance. Many indices of
lung expiratory function were decreased after intermittent oxygen
exposure at 2.0 ATA (Appendix Tables 8 and 9). During the early
post-exposure period, average values of the one-second forced
expired volume (FEVl) and peak expiratory flow rate (PEFR) were
significantly reduced by 0.52 L (11.6%) and 1.55 L/sec (15.0%),
respectively. Although maximal mid-expiratory flow rate
(FEF25_75) was reduced in 5 of the 6 subjects, the average
decrement (0.67 L/sec or 10.9%) was not statistically
significant.
In agreement with previous observations after continuous
oxygen exposure (14,15), airway resistance (Raw) was not
increased after intermittent exposure at 2.0 ATA (Appendix Table
9). Since the measured value of Raw is determined primarily by
resistance to flow through the larger, proximal airways, the
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impairment of lung expiratory function that has been found
repeatedly after either intermittent or continuous oxygen
exposure at 2.0 ATA is apparently caused by increased resistance
to flow through the smaller, peripheral airways (6,16).
In the 6 subjects who had the longest intermittent oxygen
exposures, the average value of specific lung compliance (CL/FRC)
was significantly reduced by 0.029 L/cm H20/L (20.2%) during the
early post-exposure period. At the same time in 5 of the same
subjects, the average value for density dependence of expiratory
flow rate ( Vmaxs0 ) was reduced by 10.8%, but this change was not
statistically significant. Both of these parameters were reduced
significantly after continuous oxygen exposure at 2.0 ATA (14).
Lung diffusing capacity and arterial oxygenation. The
average value for lung carbon monoxide diffusing capacity (DLco)
during the early post-exposure period was nearly identical to the
pre-exposure control value (Appendix Table 9). However, DLco
fell progressively over the next 2 days for average decrements of
8.1% on post-exposure day 1 and a statistically significant 11.7%
on post-exposure day 2 (Data not shown in Table). A similar
continuation of the post-exposure reduction in DLco was observed
after continuous oxygen exposure at 2.0 ATA for an average time
of 9.4 hours (17).
Effects of intermittent oxygen exposure at 2.0 ATA on
selected parameters of arterial oxygenation and acid-base state
are summarized in Appendix Table i0. Average alveolar-arterial
oxygen differences (N=4) measured at rest during the first and
last hours of oxygen breathing at 2.0 ATA were 45 and 59 mm Hg,
respectively. Alveolar-arterial oxygen differences were also
measured at rest and during exercise while breathing air at 1.0
ATA before and after intermittent exposure at 2.0 ATA. Average
pre-exposure values at rest and during exercise (N=5) at a mean
oxygen uptake of 1.34 L/min were 1.5 and 7.8 mm Hg, respectively.
Corresponding post-exposure values were 9.8 and 14.4 mm Hg. None
of the observed increments in alveolar-arterial oxygen
differences were statistically significant.
Although arterial oxygenation was not significantly altered
during late exposure or in the early post-exposure period, there
were statistically significant changes in several indices of
arterial acid-base state. These changes included a small but
statistically significant decrease in arterial pH during oxygen
exposure, significant reductions in arterial PCO 2 and [HC03- ] at
rest while breathing air during the early post-exposure period,
and reduction in arterial PCO 2 with concurrent elevations in
arterial pH and alveolar PO 2 during the subsequent exercise
period. These changes are generally consistent with loss of
bicarbonate during the prolonged intermittent oxygen exposure and
with mild hyperventilation during the early post-exposure period.
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Effects on Respiratory and Skeletal Muscle Strenath
Average values of maximum inspiratory and expiratory
pressures and maximum handgrip strength are summarized in
Appendix Table ii. In the 6 subjects who had the longest
intermittent oxygen exposures, maximum inspiratory pressure
during the early post-exposure period was reduced by 30.6 cm H20
(21.2%) at residual volume and by 22.7 cm H20 (17.9%) at
functional residual capacity. Concurrent values of maximum
expiratory pressure were reduced by 22.2 cm H20 (16.6%) at total
lung capacity and by 34.6 cm H20 (26.3%) at functional residual
capacity. None of the observed changes in maximum respiratory
pressures were statistically significant.
Maximum handgrip strength was reduced by only 0.8 Kg (1.5%)
during the early post-exposure period, and the tolerable duration
for sustaining 80% of maximum handgrip power, measured as an
index of endurance, was reduced by 8.8 seconds (24.9%). Neither
of these changes were statistically significant.
Effects on Card_ovascula; _uDct$on and Body Temperature
Cardiovascular parameters measured before, during, and after
intermittent oxygen exposure at 2.0 ATA include heart rate,
stroke volume, cardiac output, mean arterial blood pressure, and
systemic vascular resistance. Rectal temperature was also
measured as an index of deep body temperature. Individual and
average values are summarized in Appendix Table 12. Average
values are shown for all 7 subjects and for the 6 subjects who
had the longest exposures.
Heart rate decreased in all 7 subjects at the start of
oxygen exposure with an average decrement from 56.7 to 48.4
beats/min. Stroke volume changed less consistently with an
average increment of only 137.0 to 141.1 ml. Average cardiac
output decreased from 7.75 to 6.89 L/min, but this change was not
statistically significant. In the 6 subjects who had the longest
intermittent oxygen exposures, average heart rate increased
significantly from 48.3 beats/min at the start of exposure to
55.2 and 55.3 beats/min at 10.7 and 11.7 oxygen hours,
respectively, and to 59.0 beats/min during the last exposure
hour. The increased heart rate was associated with a significant
reduction in stroke volume from 133.5 to 105.7 ml. A similar
initial reduction and later acceleration of heart rate was found
during continuous oxygen exposure at 2.0 ATA (8).
Mean arterial blood pressure and systemic vascular
resistance did not change significantly at the start of oxygen
exposure and were not consistently altered during the course of
the exposure. There was a small but statistically significant
increase in deep body temperature from a pre-exposure value of
36.7°C to 37.0°C (N=6) during the early post-exposure period.
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In summary, the cardiovascular responses to intermittent
oxygen exposure at 2.0 ATA were generally consistent with
previously observed responses to continuous oxygen exposure at
the same pressure (8), with no prominent pathophysiologic
effects on cardiovascular function.
EVALUATION OF ORGAN SPECIFIC RESPONSES TO INTERMITTENT EXPOSURE
ON A 30:30 OXYGEN:NORMOXIC PATTERN AT 2.0 ATA.
During the final phase of this Program, 6 intermittent
oxygen exposures with the 30:30 oxygen:normoxic sequence were
completed at 2.0 ATA. The total number of subjects was limited
by the difficulty encountered in recruiting student volunteers
for an experiment that required 5 consecutive days for pre-
exposure, exposure, and post-exposure measurements, with
additional days for medical evaluation, training, and follow-up
measurements. Average values and statistical analyses of the
data for the measured organ specific responses to the 30:30
oxygen:normoxic intermittent exposure pattern are summarized in
Appendix Tables 13 to 22.
Exposure Duration and Symptoms
Of the 6 intermittent exposures that were completed on the
30:30 pattern, 4 were continued for the planned duration of 15.0
oxygen hours, and the other 2 were stopped at 13.0 hours. As was
done previously for the continuous and 60:15 intermittent
exposure series, each subject reviewed a list of symptoms at
regular intervals and rated each symptom as absent (0), mild
(i+), moderate (2+), or severe (3+). Although symptoms remained
generally mild, the first exposure was stopped at 13.0 oxygen
hours when the subject appeared to be developing prominent
decrements in visual and pulmonary function. The last exposure
was also stopped at 13.0 oxygen hours when the subject became
extremely anxious in association with chest tightness and
shortness of breath. One subject vomited several times during
the early post-exposure period.
Effects on Brain Electrical Activity
As observed previously during the continuous and 60:15
intermittent exposure series, online inspection of
electroencephalographic records revealed no evident abnormalities
of brain electrical activity.
Effects on Auditory-Vestibular Function
In agreement with previous findings after both continuous
and intermittent oxygen exposures, significant shifts in hearing
thresholds were not detected by either conventional or extended
high frequency audiometry. Post-exposure evaluations of middle
ear function by acoustic immittance and auditory brainstem
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responses as an index of neural transmission revealed no
abnormalities. Post-exposure caloric responses were also normal.
Mental Performance and Psychomotor Function
Average results of mental performance and psychomotor
function evaluations are summarized in Appendix Table 13.
Average scores for short term memory ability and number facility
were generally maintained or increased slightly at the end of the
intermittent oxygen exposure or during the early post-exposure
period. Manual dexterity scores were significantly reduced post-
exposure, with average pre and post-exposure values of 62.7 and
49.2 (-21.5%), respectively. Average visual reaction time was
reduced by 0.013 seconds at the end of oxygen exposure and
increased by 0.034 seconds during the early post-exposure period.
Neither of these changes were statistically significant.
Effects on Visual Function
Average measurements of visual responses to intermittent
oxygen exposure on the 30:30 sequence are summarized in Appendix
Tables 14-16. Average values for visual evoked cortical
responses, nearpoint accommodation, and pupil diameter were
similar before, during, and after intermittent oxygen exposure
(Appendix Table 14). Except for a minor change from 20/25 to
20/30 in one subject, visual acuities were identical before,
during, and after exposure.
Average values of peripheral visual field area measured
before, during, and after intermittent oxygen exposure are
summarized in Appendix Table 15. With respect to the control
measurement at the start of oxygen exposure, average values were
reduced by 5.5% at 8.0 oxygen hours, increased by 2.5% at 10.0
hours, reduced again by 6.4% at 13.0 hours, and decreased by 5.3%
at the end of oxygen exposure. With respect to the pre-exposure
control value, average visual field area was increased by 3.1%
during the early post-exposure period. None of the observed
changes in visual field area were statistically significant. In
contrast, average visual field areas in the 6 subjects who were
exposed on the 60:15 oxygen:normoxic sequence were significantly
reduced by 13.9% and 8.4%, respectively, at ll.2 and 13.6 oxygen
hours (Appendix Table 5).
Average electroretinographic responses (b-wave amplitude) to
3 different light intensities are summarized in Appendix Table
16. With respect to the control measurement at the start of
oxygen exposure, average responses to the lowest light intensity
fell to the lowest value (-15.6%) at 8.0 oxygen hours, then rose
to -1.3% at 12.0 hours, decreased to -6.3% at 13.0 hours, and
rose to -3.5% at the end of the exposure. Corresponding
responses to the intermediate intensity also reached the lowest
value (-26.8%) at 8.0 hours, followed by a partial recovery to an
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average decrement of 9.1% at the end of oxygen exposure. In
agreement with observed responses to the two lower intensities,
average responses to the brightest light intensity fell to the
lowest value (-14.3%) at 8.0 oxygen hours. Thereafter, these
responses recovered fully to reach an average increment of 4.0%
at the end of intermittent oxygen exposure. With respect to pre-
exposure control values, average changes during the early post-
exposure period were -11.3%, -i1.8%, and +5.9%, respectively,
for the lowest, intermediate, and highest light intensities. Of
all the observed changes in ERG b-wave amplitude during and after
intermittent oxygen exposure, only the 26.8% decrement in
response to the intermediate light intensity at 8.0 oxygen hours
and the 9.1% decrement in response to the same light intensity at
the end of oxygen exposure were statistically significant.
Average percent decrements in ERG b-wave amplitude
calculated from individual average responses to all 3 light
intensities are shown in Appendix Figure 15 for all 6 subjects
exposed on the 30:30 oxygen:normoxic sequence, along with
corresponding data for 7 subjects exposed continuously and 6
subjects exposed intermittently on the 60:15 sequence (Shown
previously in Appendix Figure 10). With respect to the initial
control value, average results for the 6 subjects on the 30:30
sequence were essentially unchanged through 6.0 oxygen hours,
fell abruptly to an average decrement of 19.5% at 8.0 hours, and
then recovered progressively to reach an average decrement of
only 3.3% at the end of the intermittent exposure. Progressive
recovery of ERG b-wave amplitude during the second half of the
intermittent exposure on the 30:30 sequence contrasted sharply
with the concurrent progressive decrements in b-wave amplitude
observed during both continuous oxygen exposure and intermittent
exposure on the 60:15 sequence.
Rate and Pattern of Pulmonary Ventilation
Average measurements of ventilatory responses to
intermittent oxygen exposure on the 30:30 sequence are summarized
in Appendix Table 17. As noted previously at the start of either
continuous or intermittent oxygen exposure, expiratory minute
volume increased significantly during the transition from
breathing air at 1.0 ATA to breathing oxygen at 2.0 ATA. Both
the average pre-exposure value of 7.30 L/min and the initial
exposure value of 10.38 L/min were used as control values for
subsequent measurements at 2.0 or 1.0 ATA. With respect to these
control values, there were no significant changes in expiratory
minute volume during either the intermittent oxygen exposure at
2.0 ATA or the early post-exposure period at 1.0 ATA. Similarly,
there were no significant changes in respiratory rate, tidal
volume, or rate of CO 2 elimination during the exposure or post-
exposure periods.
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Average end-tidal PCO 2, after decreasing significantly from
a pre-exposure value of 40.2 mmHg to 33.8 mm Hg at the start of
exposure, increased significantly to 36.2 mm Hg at 7.6 oxygen
hours. There were no other significant changes in end-tidal PCO 2
except for the expected elevation from 33.2 to 37.2 mm Hg during
the reverse transition from oxygen breathing at 2.0 ATA to air
breathing at 1.0 ATA. The observed elevation from 33.8 mm Hg at
the start of intermittent exposure to 36.2 mm Hg at 7.6 oxygen
hours may have been related to the fact that this measurement was
made at 0300 to 0400 hours when the subjects would normally have
been asleep. A reduced ventilatory response to metabolically
produced CO 2 with a reciprocal elevation in arterial and end-
tidal PCO 2 has been observed during sleep (18) and in normal men
who were awakened intermittently during the night (19).
Effects oD Pulmonary Function
Average pulmonary symptom ratings for the 6 subjects who
were exposed on the 30:30 oxygen:normoxic sequence are plotted
against exposure duration in Appendix Figure 16 along with the
pulmonary symptom curves shown previously(Appendix Figure 11)
for continuous exposure and for intermittent exposure on the
60:15 sequence. As expected, pulmonary symptoms developed more
slowly and were less severe on the 30:30 sequence than for the
previous intermittent exposures on the 60:15 sequence. Average
symptom ratings at the end of each of the 3 exposure series were
1.0 at 14.3 oxygen hours on the 30:30 sequence, 2.0 at 13.6
oxygen hours on the 60:15 sequence, and 2.1 at 9.2 hours of
continuous exposure.
Rate of decrease in vital capacity. Average values for
selected lung volumes and flow rates measured before, during, and
after intermittent exposure on the 30:30 sequence are summarized
in Appendix Table 18. Average percent changes in vital capacity
were selected for comparison with similar data obtained during
continuous exposure (N=16) and intermittent exposure on the 60:15
sequence (N=6) (Appendix Figure 17). Average vital capacity
decrements for the 6 subjects exposed intermittently on the 30:30
sequence initially were nearly superimposed on the curve for
continuous exposure to reach an average decrement of 6.0% at 8.0
oxygen hours, then remained essentially constant, crossing the
curve for intermittent exposure on the 60:15 sequence at 11.1
hours to end at an average decrement of 6.1% at 14.3 oxygen
hours. Individual changes in vital capacity at the end of oxygen
exposure varied from -9.2% to +1.4% of the initial control value.
All of the changes in vital capacity observed from 8.0 to 14.3
oxygen hours were statistically significant. Although
intermittent exposure on the 30:30 sequence allowed nearly 15
hours of oxygen breathing at 2.0 ATA with a relatively small
change in vital capacity, as predicted, the observation of vital
capacity decrements that initially exceeded those found
previously for the 60:15 sequence was not expected.
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Post-exposure evaluation of pulmonary function. Average
values for selected components of extensive evaluations of
pulmonary function that were performed before and after
intermittent oxygen exposure at 2.0 ATA are summarized in
Appendix Table 19. The average changes were generally smaller
than those found after intermittent exposure on the 60:15
sequence (Appendix Table 9) with only a few exceptions. One of
the exceptions was a consistent reduction in specific lung
compliance in all 6 subjects for an average decrement of 23.8%
after intermittent exposure on the 30:30 sequence. This
statistically significant change was very similar to the
corresponding value of 20.2% found after exposure on the 60:15
sequence.
Lung carbon monoxide diffusing capacity was also reduced by
a small, but statistically significant, average change of -4.9%
during the early post-exposure period, with subsequent,
significant changes of -11.3%, -11.3%, and -12.0% on post-
exposure days i, 2, and 3, respectively. After intermittent
exposure on the 60:15 sequence, lung carbon monoxide diffusing
capacity was not changed (+0.6%) during the early post-exposure
period, with average changes of -8.1% on post-exposure day 1 and
a statistically significant -11.7% on post-exposure day 2.
Average values for selected parameters of arterial
oxygenation and acid-base state measured before, during, and
after intermittent exposure on the 30:30 sequence are summarized
in Appendix Table 20. None of the observed changes were
statistically significant, and most of the average values
measured pre-exposure and during the first 30 minutes of oxygen
breathing were similar to corresponding values measured during
the last 30 minutes of exposure and during the early post-
exposure period.
Effects on Respiratory and Skeletal Muscle Strenqth
Average values of maximum inspiratory and expiratory
pressures and maximum handgrip strength are summarized in
Appendix Table 21. Maximum inspiratory pressure during the early
post-exposure period was reduced by 19.5 cm H20 (13.3%) at
residual volume and by 4.0 cm H20 (3.4%) at functional residual
capacity. Concurrent values of maximum expiratory pressure were
reduced by 24.5 cm H20 (17.7%) at total lung capacity and by 15.3
cm H20 (i1.6%) at functional residual capacity. None of the
observed changes in maximum respiratory pressures were
statistically significant.
Maximum handgrip strength was reduced by 3.6 Kg (7.2%)
during the early post-exposure period, and the tolerable duration
for sustaining 80% of maximum handgrip power, measured as an
index of endurance, was reduced by 7.4 seconds (17.3%). Neither
of these changes were statistically significant.
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Effects on Cardiovascular Function and Body Temperature
Average values of heart rate, stroke volume, cardiac output,
mean arterial blood pressure, systemic vascular resistance, and
deep body temperature measured before, during, and after
intermittent oxygen exposure at 2.0 ATA are summarized in
Appendix Table 22. Average heart rate increased significantly
from 53.8 to 62.2 beats/min at the start and end of intermittent
oxygen exposure, respectively. A concurrent reduction in average
stroke volume from 102.6 to 82.2 ml was not statistically
significant. There were no significant changes in cardiac
output, mean arterial blood pressure, or systemic vascular
resistance. Average deep body temperature decreased
significantly from 37.0°C at the start of oxygen exposure to
36.6°C at 8.0 oxygen hours. It then increased during the
remainder of the intermittent exposure to reach an average value
of 37.3°C during the early post-exposure period that was
significantly larger than the pre-exposure value of 37.0°C.
In summary, the cardiovascular responses to intermittent
oxygen exposure at 2.0 ATA on the 30:30 pattern were generally
consistent with previously observed responses to both
intermittent exposure on the 60:15 pattern (Appendix Table 12)
and to continuous oxygen exposure at the same pressure (8), with
no prominent pathophysiologic effects on cardiovascular function.
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INTERPRETATION AND RELEVANCE OF RESULTS
In agreement with results of the previous continuous oxygen
exposures at 2.0 ATA in Predictive Studies V, intermittent oxygen
exposure at 2.0 ATA on either the 60:15 or 30:30 oxygen:normoxic
sequence had little or no effect on brain electrical activity,
auditory and vestibular function, mental performance, and
psychomotor function. Observed changes in the rate and pattern
of pulmonary ventilation were consistent with previously
documented physiological responses to hyperoxia (3), except for
an elevation in respiratory rate that was statistically
significant at the end of intermittent oxygen exposure on the
60:15 sequence. Cardiovascular responses to intermittent oxygen
exposure were also consistent with previously observed
physiological responses, except that average heart rates were
significantly increased by about 22% at the end of exposure on
the 60:15 pattern and by about 15% on the 30:30 pattern. Similar
increments in respiratory and heart rates also occurred during
prolonged, continuous oxygen exposure at 2.0 ATA (7,8).
The most prominent toxic effects of intermittent oxygen
exposure at 2.0 ATA, again in agreement with results of the
previous continuous exposures, were manifested as significant
alterations in specific aspects of visual function (retinal
electrical activity and peripheral vision) and in several indices
of pulmonary function. The physiological and operational
relevance of the observed changes will be emphasized in the
remainder of this discussion.
Comparative Rates of Development of Visual and Pulmonary Effects
of Oxyqen Toxicity durinq Continuous and Intermittent Oxyqen
Exposure at 2.0 ATA
Rates of decline in ERG b-wave amplitude and forced vital
capacity in the same 7 subjects exposed continuously to oxygen at
2.0 ATA are shown in Appendix Figure 18. Average decrements in
ERG b-wave start earlier and are larger than corresponding FVC
decrements. Since the lung is exposed to a higher oxygen
pressure than any other organ, these data indicate that retinal
bipolar and glial cells, which produce the ERG b-wave, are more
sensitive to oxygen toxicity than the pulmonary cells that are
responsible for the still poorly understood fall in vital
capacity. Previous in vitro studies have also shown that
respiration of rat brain slices is inactivated before that of
lung slices during exposure to the same oxygen pressure (20-22).
Our data show that ERG b-wave amplitude is decreased
prominently, along with a smaller but statistically significant
reduction in peripheral visual field area (12), before the
occurrence of convulsions or detectable decrements in other CNS
functions during continuous oxygen exposure at 2.0 ATA. These
results appear to indicate that retinal function, by virtue of
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specific sensitivities of retinal cells and/or the oxygen dose to
which the retina is exposed, is more susceptible to oxygen
poisoning than other critical CNS functions.
During intermittent oxygen exposure at 2.0 ATA on the 60:15
oxygen:normoxic sequence, average measurements in 6 subjects
again show that decrease in ERG b-wave amplitude precedes the
fall in vital capacity (Appendix Figure 19). During intermittent
exposure, however, changes in both ERG b-wave amplitude and vital
capacity are delayed and smaller than the corresponding changes
previously observed during continuous exposure.
Average changes in ERG b-wave amplitude and FVC are shown in
Appendix Figure 20 for the 6 subjects who were intermittently
exposed on the 30:30 oxygen:normoxic sequence. The pattern of
results found in this series of exposures differs significantly
from that found during either continuous exposure or the 60:15
intermittent exposure series. In contrast to the progressive
decrements in both FVC and ERG b-wave amplitude that were
observed previously, average FVC on the 30:30 sequence reached an
average decrement of 6.0% at 8.0 oxygen hours and then
essentially plateaued during the remainder of the exposure, while
the ERG b-wave amplitude actually recovered to an average
decrement of 3.3% at the end of exposure after reaching a maximal
decrement of 19.5% at 8.0 oxygen hours. Possible mechanisms for
the apparent partial recovery during continued intermittent
exposure will be discussed below.
Extension of oxyqen Tolerance on the 60:15 Oxyqen:Normoxic
Sequence
Average changes in both ERG b-wave amplitude and FVC for 7
subjects exposed continuously to oxygen at 2.0 ATA and for the 6
subjects exposed intermittently on the 60:15 sequence are shown
in Appendix Figure 21. The data reflect increased tolerances to
both visual and pulmonary effects of oxygen toxicity in the
subjects who were exposed intermittently. Although the
horizontal distances or exposure durations between the curves are
roughly similar for corresponding effects, it is not likely that
degrees of oxygen tolerance for a single pattern of intermittent
exposure are truly equal for the observed visual and pulmonary
effects of oxygen toxicity.
Local differences in blood flow and metabolic rate cause the
oxygen tensions to vary widely among different tissues and organs
for any level of inspired PO 2 (3,23). In addition to local
differences in oxygen dose, the nature and capacity of
antioxidant defenses are also likely to vary at different organ,
tissue, or even cellular sites. For example, results of the
previous continuous oxygen exposures of Predictive Studies V have
shown that ERG b-wave amplitude and peripheral visual field area,
both visual functions that originate in the retina, are impaired
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at different rates during oxygen exposure at both 3.0 and 2.0 ATA
(12).
During intermittent exposure to oxygen at any ambient
pressure, the cyclical insertion of recovery periods imposes
another level of complexity by superimposing the influences of
varying rates of recovery in different organ systems and from
different effects of oxygen toxicity (23). Average data from the
30:30 intermittent exposure series (Appendix Figure 20) indicates
the possibility of yet another level of complexity related to
stabilization or actual reversal of some toxic effects while the
oxygen exposure is still in progress. For all of these reasons,
degrees of oxygen tolerance extension for a single pattern of
intermittent exposure at a given oxygen pressure are likely to
vary for different toxic effects and among different organ
systems (23).
Extension of Oxyqen Tolerance on the 30:30 Oxyqen:Normoxic
Sequence
With respect to the 60:15 oxygen:normoxic sequence, the
30:30 sequence halves the toxic oxygen period and doubles the
normoxic recovery interval. On the basis of general principles
of oxygen tolerance extension by intermittent exposure, and in
agreement with results of the 60:15 exposure sequence and the
extensive animal studies that were completed previously under
this Program, it was anticipated that visual and pulmonary
effects of oxygen toxicity would be undetectable or small in
magnitude throughout the 15.0 oxygen exposure hours that were
planned for the 30:30 sequence (total exposure duration of 29.5
hours).
During the intermittent exposure of the first subject to be
studied on the 30:30 protocol, it was therefore surprising when
both ERG b-wave amplitude and vital capacity decreased at faster
rates than those found during the previously completed 60:15
exposure sequence. This unexpected observation led to the
decision to terminate the first exposure of the new sequence at
13.0 oxygen hours rather than the planned 15.0 hours. Since this
decision had to be made in advance in order to complete all of
the planned measurements, it could not be readily changed when
the final exposure measurements showed partial reversals of both
visual and pulmonary effects of oxygen toxicity. However, the
next 4 intermittent exposures were all continued for the full
15.0 oxygen exposure hours. As stated previously, the last
exposure was also stopped at 13.0 oxygen hours when the subject
became extremely anxious in association with chest tightness and
dyspnea.
Although the biochemical mechanisms responsible for
extension of oxygen tolerance by systematic alternation of oxygen
and normoxic exposure periods are not known, it is likely that
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partial reversals of toxic effects during the normoxic recovery
periods play a major role. The animal studies performed during
the early years of this Program showed that essentially complete
recovery from each successive oxygen exposure period could be
provided by selecting appropriate lengths for the alternating
oxygen exposure and normoxic recovery periods. However, the use
of survival time as an index of oxygen tolerance, although useful
for statistical validation of effective intermittent exposure
patterns in large numbers of rats, provided limited insights into
possible mechanisms for the observed benefits.
The observation that initial decrements in FVC and ERG b-
wave amplitude were stabilized or partially reversed during
continued intermittent oxygen exposure on the 30:30 sequence
(Appendix Figures 15 and 17) indicates that during the final
hours of exposure the degree of recovery that occurred during
each normoxic interval must have equalled or exceeded the
cumulative toxic effects caused by the preceding oxygen period
for both visual and pulmonary manifestations of oxygen toxicity.
These apparently enhanced capacities for recovery from oxygen
poisoning were not evident during the first 8 to 10 hours of
exposure (expressed as cumulative oxygen time by omitting the
intermittent periods of normoxia) when the degrees of visual and
pulmonary oxygen tolerance extension provided by the 60:15
exposure sequence were overtly equal to or exceeded those
provided by the 30:30 sequence.
It is important to recognize that the decrements in visual
and pulmonary function that were measured during the 30:30
intermittent exposure pattern exceeded those associated with the
60:15 pattern only when both sets of data are plotted against
cumulative oxygen hours of exposure. When the observed results
are plotted against duration of exposure expressed as real time
by including the cumulative normoxic intervals, the average
decrements in visual and pulmonary function associated with the
30:30 pattern are smaller than the corresponding decrements for
the 60:15 pattern at any selected duration of total exposure
time (Appendix Figures 22 and 23). This is as expected, because
it is inconceivable that the 30:30 intermittent exposure pattern,
which halves the oxygen exposure period and doubles the normoxic
recovery period with respect to the 60:15 pattern, could produce
greater degrees of oxygen poisoning at any duration of real time.
Possible Mechanisms for Oxyqen Tolerance Extension durinq
Intermittent Exposure
It is now well established that exposure to hyperoxia
increases the rates of production of active species that are
concurrently opposed by a variety of antioxidant defenses
(24,25). At a sufficiently high oxygen pressure and/or for a
sufficiently prolonged duration of exposure, oxidant damage to
cells and tissues occurs when antioxidant defenses are
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overwhelmed. Periodic interruption of oxygen exposure by
restoration of normoxia should allow antioxidant defenses to be
maintained or possibly even enhanced.
Frank et al (26) found that tolerance to oxygen exposure at
1.0 ATA could be greatly increased in rats by a "type" of
intermittent exposure in which the rats were exposed to oxygen
for 48 hours, returned to air for 12 to 24 hours, then reexposed
to oxygen for 72 to 168 additional hours. Whereas continuous
oxygen exposure for 72-168 hours was lethal for all control rats,
the pre-exposed rats survived the additional exposure with only
slight pulmonary edema. The increased oxygen tolerance was
associated with statistically significant increments in pulmonary
concentrations of superoxide dismutase, catalase, and glutathione
peroxidase.
Harabin et al (27) studied the role of antioxidant enzymes
in the increased oxygen tolerance afforded to guinea pigs and
rats exposed intermittently to oxygen at 2.8 ATA in a cycle that
alternated 10-minute oxygen periods with 2.5-minute intervals of
air breathing (0.59 ATA PO2). Intermittent exposure
significantly increased convulsion and survival times in both
species. Brain antioxidant enzyme activities were not
significantly increased in either species. Lung superoxide
dismutase activities were significantly increased during
intermittent exposure in both species and were also increased in
the rat during continuous exposure. In the guinea pig,
activities of glutathione peroxidase in both lung and brain, and
lung catalase activities were reduced further during continuous
than during intermittent exposure. As indicated by the authors,
these complex results did not fully explain the observed
increments in oxygen tolerance. Only one pattern of intermittent
exposure was studied at a single pressure.
Our results appear to indicate that the 60:15 sequence
afforded greater protection of oxygen tolerance than the 30:30
sequence during the initial hours of intermittent exposure, but
eventually became overwhelmed as the exposure continued. On the
other hand, the 30:30 sequence was relatively ineffective
initially, but then became sufficiently effective to stabilize or
reverse earlier decrements in both visual and pulmonary function
during the final hours of intermittent exposure. It is of
interest that the changes in ERG b-wave amplitude appeared to
show these effects more clearly than concurrent changes in FVC.
This may reflect the fact that the ERG b-wave represents a
composite response of two retinal cell types (bipolar and glial
cells), while the changes in FVC are probably more complex and
can be influenced by more variables.
One possible interpretation of our results can be based on
the hypothesis that extension of oxygen tolerance by intermittent
exposure depends not only upon cyclical periods of recovery from
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oxygen poisoning, but also involves the concurrent augmentation
of antioxidant defenses or some other means of oxygen tolerance
enhancement. Previous animal studies have shown that antioxidant
defenses can be enhanced by sufficiently prolonged exposure to
toxic, sublethal levels of hyperoxia (28,29). It is possible
that the 60:15 intermittent exposure pattern, by virtue of an
inherently greater level of toxicity, initiated the enhancement
of antioxidant defenses at an earlier time than the 30:30
pattern, but was unable to sustain the level of production
required for continued protection. If the proposed hypothesis
can be confirmed, it may be possible to increase the benefits of
intermittent exposure by selecting appropriate patterns for
different parts of a prolonged exposure, or by basing the choice
of a single pattern on the expected duration of exposure.
Operational Relevance of Observed Results
Optimization of oxygen tolerance extension by intermittent
hyperoxic exposure will provide prominent and permanent
enhancement of diving operations, decompression methods, and
hyperoxygenation therapy. The research results are relevant to
both procedure and probability of success in all forms of diving
and decompression sickness therapy. Extension of CNS (visual)
and pulmonary oxygen tolerance to increased oxygen pressures
relates specifically and critically to both safety and
operational effectiveness in underwater operations, as well as to
improvement in therapy of gas lesion diseases. Although
extension of oxygen tolerance by intermittent exposure has been
studied only at rest to date, concurrent studies indicate that
the adverse effects of exercise on oxygen tolerance may be
avoided by preventing the hypercapnia and associated increments
in brain blood flow and oxygen dose that occur during oxygen
breathing at increased ambient pressures (30). Validation of
this working hypothesis will provide a basis for extension of
oxygen tolerance during exercise as well as at rest.
Our results show that both visual and pulmonary oxygen
tolerance can be extended significantly at 2.0 ATA by systematic
alternation of oxygen and normoxic exposure periods. They also
show clearly for the first time in man or in animals that early
toxic effects on the eye and lung can be stabilized or reversed
at least partially during continued intermittent exposure with an
appropriate combination of oxygen exposure and normoxic recovery
periods. The extents to which such reversals will occur at other
oxygen pressures and with other effects of oxygen toxicity remain
to be determined. Elucidation of the mechanisms for such
responses should provide information that can be widely exploited
in the development of more effective means for extension of
oxygen tolerance than those that are now available.
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Appendix Figure 8
EXTENSION OF SURVIVAL TIME IN RATS
BY INTERMITTENT OXYGEN EXPOSURE
NO DEATHS AT 60 HOURS ON
120:120 PATTERN AT 1.5 ATA
OR AT 67 HOURS ON
60:180 PATTERN AT 2.0 ATA
20-rain 02
1.5 ATA
20-min 02
2.0 ATA
60-rain 02
4.0 ATA
I i I i I i I i I L I i
0 20 4.0 60 80 1O0
NORMOXIC INTERVAL
I i I i I i I
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DURATION (min)
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Appendix Table 1
INTERMITTENT OXYGEN EXPOSURE PATTERNS FOR
OPTIMIZATION OF OXYGEN TOLERANCE EXTENSION IN RATS
02 EXPOSURE
(ATA) (Min)
20
4.0 60
120
20
2.0 60
120
20
1.5 60
120
NORMOXIC INTERVAL (Minutes)
i0 15 20 30 60 120
X X
X
X
X
X
X
X X
X X
X
X
X
X
X
X X
X X
X X
X X X
180
X
X
Appendix Table 2
INCREASE IN MEDIAN SURVIVAL TIME WITH INCREASING DURATION OF
NORMOXIC INTERVAL DURING INTERMITTENT OXYGEN EXPOSURE IN RATS
02 EXPOSURE
(ATA) (Min)
SLOPE OF MEDIAN SURVIVAL TIME INCREMENT
(Hours per Minute of Normoxic Interval)
4.0
20 0.14
60 0.04
120 0.02
2.0
20 1.31
60 0.03
120 0.i0
1.5
20 1.64
60 0.42
120 0.18
Appendix Table 3
EFFECTS OF INTERMITTENT OXYGEN EXPOSURE AT 2.0 ATA
ON MENTAL PERFORMANCE AND PSYCHOMOTOR FUNCTION IN MAN
60:15 OXYGEN:NORMOXIC SEQUENCE
DIFFERENCES
PRE START END POST END- POST-
EXP EXP EXP EXP START PRE
1 ATA 2 ATA 2 ATA 1 ATA 2 ATA 1 ATA
Visual Digit Span Test Of Short Term Memory Ability
(Correct Responses)
N 7 7 7 6 7 6
MEAN 34.4 33.4 34.6 33.8 i.i -i.0
SD 5.9 4.9 6.4 8.8 7.7 8.1
SEM 2.2 1.9 2.4 3.6 2.9 3.3
N 6 6 6 5 6 5
MEAN 33.0 33.7 33.3 32.6 -0.3 -0.6
SD 4.9 5.4 6.0 9.3 7.3 9.0
SEM 2.0 2.2 2.4 4.2 3.0 4.0
Key Insertion Test Of Finger Dexterity Ability
(Correct Responses)
N 4 4 4 4 4 3
MEAN 38.5 42.5 41.3 31.3 -i. 3 -4.3
SD 9.5 5.1 6.3 5.7 6.8 15.0
SEM 4.7 2.5 3.2 3.3 3.4 8.6
Operations Test Of Number Facility And General Reasoning Ability
[Correct Responses - i/3 (Incorrect Responses)]
N 7 7 7 7 7 7
MEAN 39.3 44.1 44.2 42.2 0.1 2.9
SD 9.4 6.2 7.6 7.3 5.3 9.8
SEM 3.5 2.4 2.9 2.8 2.0 3.7
N 6 6 6 6 6 6
MEAN 39.2 44.2 43.7 41.8 -0.5 2.6
SD 10.2 6.8 8.2 7.9 5.5 10.7
SEM 4.2 2.8 3.3 3.2 2.3 4.4
Visual Reaction Time Test Of Response Speed Ability
(Seconds)
N 7 7 7 7 7 7
MEAN 0.283 0.282 0.322 0.336 0.040 0.053
SD 0.029 0.036 0.067 0.080 0.045 0.060
SEM 0.011 0.014 0.025 0.030 0.017 0.023
N 6 6 6 6 6 6
MEAN 0.289 0.292 0.339 0.347 0.047* 0.059
SD 0.027 0.026 0.055 0.081 0.045 0.064
SEM 0.011 0.011 0.022 0.033 0.018 0.026
* Difference from control statistically significant by paired t-test
(p _ o.o5_.
Appendix Table 4 (i of 2)
EFFECTS OF INTERMITTENT OXYGEN EXPOSURE AT 2.0 ATA
ON VISUAL FUNCTION IN MAN
60:15 OXYGEN:NORMOXIC SEQUENCE
DIFFERENCES
PRE START END POST END- POST-
EXP EXP EXP EXP START PRE
1 ATA 2 ATA 2 ATA 1 ATA 2 ATA 1 ATA
Visual Evoked Response (Latency, msec)
N 7 7 7 7 7 7
MEAN 111.28 113.96 117.20 116.53 3.24 5.25
SD 9.63 6.90 7.80 10.76 7.71 12.83
SEM 3.64 2.61 2.95 4.07 2.91 4.85
N 6 6 6 6 6 6
MEAN 108.58 112.46 118.25 116.42 5.79* 7.83
SD 7.09 6.16 7.99 11.78 4.07 11.89
SEM 2.89 2.52 3.26 4.81 1.66 4.85
Accommodation (Nearpoint, cm)
N 7 6 7 7 6 7
MEAN 11.65 12.52 12.75 12.52 0.66 0.87
SD 2.21 2.76 3.58 2.79 1.19 1.21
SEM 0.83 1.13 1.35 1.05 0.49 0.46
N 6 6 6 6 6 6
MEAN 11.74 12.52 13.18 12.75 0.66 1.00
SD 2.40 2.76 3.71 2.98 1.19 1.27
SEM 0.98 1.13 1.52 1.22 0.49 0.52
Pupil Diameter (nun)
N 7 7 7 7 7 7
MEAN 4.1 4.3 4.2 4.1 -0.i -0.I
SD 0.7 0.6 0.3 0.8 0.5 0.7
SEM 0.3 0.2 0.i 0.3 0.2 0.3
N 6 6 6 6 6 6
MEAN 4.2 4.3 4.3 4.1 0.0 -0.1
SD 0.8 0.7 0.3 0.9 0.5 0.7
SEM 0.3 0.3 0.I 0.4 0.2 0.3
* Difference from control statistically significant by paired t-test
(p <_ 0.o5).
Appendix Table 4 (2 of 2)
EFFECTS OF INTERMITTENT OXYGEN EXPOSURE AT 2.0 ATA
ON VISUAL FUNCTION IN MAN
60:15 OXYGEN:NORMOXIC SEQUENCE
Visual Acuity
HK 20/20 20/25 20/20 20/25
KC 20/20 20/20 20/25 20/20
MM 20/20 20/20 20/25 20/20
RI 20/25 20/25 20/25 20/25
MB 20/25 20/25 20/20 20/20
GZ 20/20 20/20 20/20 20/20
AI 20/20 20/20 20/20 20/20
PRE START END POST
EXPOSURE EXPOSURE EXPOSURE EXPOSURE
1 ATA 2 ATA 2 ATA 1 ATA
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Appendix Table 9 (i of 2)
EFFECTS OF INTERMITTENT OXYGEN EXPOSURE AT 2.0 ATA
ON PULMONARY FUNCTION IN MAN
60:15 OXYGEN:NORMOXIC SEQUENCE
PRE POST POST- PRE POST POST-
EXP EXP PRE _ EXP EXP PRE
Slow Vital Capacity
(L)
Inspiratory Capacity
(L)
N 7 7 7 7 7 7
MEAN 5.35 4.80 -0.54* 3.49 2.86 -0.63*
SD 0.56 0.65 0.45 0.52 0.83 0.41
SEM 0.21 0.25 0.17 0.20 0.31 0.16
N 6 6 6 6 6 6
MEAN 5.20 4.62 -0.59* 3.38 2.66 -0.72*
SD 0.45 0.46 0.47 0.47 0.70 0.37
SEM 0.18 0.19 0.19 0.19 0.28 0.15
N
MEAN
SD
SEM
N
MEAN
SD
SEM
Expiratory Reserve Volume
(L)
Total Lung Capacity
(L)
7 7 7 7 7 7
1.85 1.95 0.09 6.13 5.48 -0.65*
0.38 0.39 0.23 0.70 0.82 0.40
0.14 0.15 0.09 0.26 0.31 0.15
6 6 6 6 6 6
1.82 1.96 0.14 6.02 5.34 -0.68*
0.40 0.42 0.21 0.69 0.79 0.43
0.16 0.17 0.08 0.28 0.32 0.18
Difference from control statistically significant by paired
t-test (p _ 0.05).
Appendix Table 9 (2 of 2)
EFFECTS OF INTERMITTENT OXYGEN EXPOSURE AT 2.0 ATA
ON PULMONARY FUNCTION IN MAN
60:15 OXYGEN:NORMOXIC SEQUENCE
PRE POST POST- PRE POST POST-
EXP EXP PRE a EXP EXP PRE
CO Diffusing Capacity
(ml/CO/mmHg/min)
Density Dependence of Flow
(% _ #maxso)
N 7 7 7 6 6 6
MEAN 34.0 33.7 -0.3 43.7 35.3 -8.4
SD 4.1 4.1 2.0 9.3 20.0 24.0
SEM 1.5 1.5 0.7 3.8 8.2 9.8
N 6 6 6 5 5 5
MEAN 33.1 33.4 0.3 44.0 33.2 -10.8
SD 3.6 4.4 1.3 10.4 21.6 26.0
SEM 2.5 1.8 0.5 4.7 9.6 11.6
Airway Resistance
(cm H20/L/sec)
Specifc Lung Compliance
(L/cm H20/L)
N 7 7 7 7 7 7
MEAN 2.07 2.11 0.04 0.139 0.112 -0.028*
SD 0.40 0.52 0.20 0.032 0.032 0.023
SEM 0.15 0.20 0.07 0.012 0.012 0.009
N 6 6 6 6 6 6
MEAN 1.95 1.94 -0.01 0.144 0.114 -0.029*
SD 0.23 0.30 0.19 0.032 0.034 0.025
SEM 0.09 0.12 0.08 0.013 0.014 0.010
Difference from control statistically significant by paired
t-test (p S 0.05).
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Appendix Table ii
EFFECTS OF INTERMITTENT OXYGEN EXPOSURE AT 2.0 ATA
ON RESPIRATORY AND SKELETAL MUSCLE STRENGTH
60:15 OXYGEN:NORMOXIC SEQUENCE
PRE POST POST- PRE POST POST-
EXP EXP PRE a EXP EXP PRE
Maximum Inspiratory Pressure (cm H20)
At Residual Volume At Functional Residual
Capacity
N 7 7 7 7 7 7
MEAN 134.3 109.2 -25.1 119.3 99.8 -19.4
SD 41.3 34.5 42.0 49.5 33.3 44.9
SEM 15.6 13.0 15.9 18.7 12.6 17.0
N 6 6 6 6 6 6
MEAN 144.1 113.5 -30.6 126.8 104.1 -22.7
SD 35.3 35.7 43.2 49.6 34.4 48.2
SEM 14.4 14.6 17.6 20.2 14.0 19.7
Maximum Expiratory Pressure (cm E20)
At Total Lung Capacity At Functional Residual
Capacity
N 7 7 7 7 7 7
MEAN 127.9 110.6 -17.4 124.0 96.4 -27.6
SD 41.8 30.9 33.7 42.7 43.6 48.0
SEM 15.8 11.7 12.8 16.1 16.5 18.1
N 6 6 6 6 6 6
MEAN 133.8 111.6 -22.2 131.7 97.2 -34.6
SD 42.6 33.7 34.2 41.0 47.8 48.5
SEM 17.4 13.8 14.0 16.8 19.5 19.8
Maximum Handgrip
Strength (Kg)
Duration for 80% Maximum
Handgrip (See)
N 7 7 7 7 7 7
MEAN 51.4 49.6 -i. 7 31.2 23.6 -7.6
SD 4.2 8.0 6.7 18.6 18.6 9.5
SEM 1.6 3.0 2.5 7.0 7.0 3.6
N 6 6 6 6 6 6
MEAN 51.7 50.8 -0.8 35.3 26.5 -8.8
SD 4.5 8.0 6.8 16.6 18.5 9.9
SEM 1.8 3.3 2.8 6.8 7.6 5.0
Difference from control signficantly significant by paired
t-test (p < 0.05).
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Appendix Table 13
EFFECTS OF INTERMITTENT OXYGEN EXPOSURE AT 2.0 ATA
ON MENTAL PERFORMANCE AND PSYCHOMOTOR FUNCTION IN MAN
30:30 OXYGEN:NORMOXIC SEQUENCE
DIFFERENCES
PRE START END POST END- POST-
EXP EXP EXP EXP START PRE
1 ATA 2 ATA 2 ATA 1 ATA 2 ATA 1 ATA
Visual Digit Span Test Of Short Term Memory Ability
(Correct Responses}
N 6 6 6 6 6 6
MEAN 31.2 32.8 32.2 36.0 -0.7 4.8
SD 5.8 4.3 4.5 4.5 5.8 5.4
SEM 2.4 1.8 1.8 1.8 2.4 2.2
Key Insertion Test of Finger Dexterity Ability
(Correct Responses)
N 6 6 6 6 6 6
MEAN 62.7 52.8 52.7 49.2 -0.2 -13.5"
SD 4.3 11.5 8.0 10.2 9.2 7.5
SEM 1.8 4.7 3.3 4.2 3.8 3.1
operations Test of Number Facility and General Reasoning Ability
[Correct Responses - 1/3 (Incorrect Responses}]
N 6 6 6 6 6 6
MEAN 69.5 68.6 72.2 69.6 3.6 0.i
SD 8.5 ii.i 9.6 7.7 3.9 6.8
SEM 3.5 4.5 3.9 3.1 1.6 2.8
Visual Reaction Time Test of Response Speed Ability
(Seconds}
N 6 6 6 6 6 6
MEAN 0.283 0.304 0.292 0.318 -0.013 0.034
SD 0.017 0.027 0.032 0.047 0.021 0.037
SEM 0.007 0.011 0.013 0.019 0.009 0.015
Difference from control statistically significant by paired
t-test (p S 0.05).
Appendix Table 14
EFFECTS OF INTERMITTENT OXYGEN EXPOSURE AT 2.0 ATA
ON VISUAL FUNCTION ZNMAN
30:30 OXYGEN:NORMOXIC SEQUENCE
DIFFERENCES
PRE START END POST END- POST-
EXP EXP EXP EXP START PRE
1 ATA 2 ATA 2 ATA 1 ATA 2 ATA 1 ATA
Visual Evoked Response (Latency, msec)
N 6
MEAN 108.73
SD 3.48
SEM 1.42
6 6
108.42 -0.32
8.69 6.91
3.55 2.82
Accommodation (Nearpoint, cm)
N 6 6 6 6 6 6
MEAN 10.16 10.45 10.42 10.33 -0.03 0.17
SD 1.47 1.36 1.51 1.37 0.25 0.46
SEM 0.60 0.56 0.62 0.56 0.i0 0.19
Pupil Diameter (nun)
N 6 6 6 6 6 6
MEAN 3.9 4.6 4.5 3.9 -0.i 0.0
SD 0.9 0.7 0.7 0.8 i.i 0.4
SEM 0.4 0.3 0.3 0.3 0.5 0.i
Visual Acuity
CS 20/30 20/30 20/30 20/30
EK 20/25 20/25 20/30 20/30
JB 20/20 20/20 20/20 20/20
MS 20/20 20/20 20/20 20/20
PS 20/20 20/20 20/20 20/20
CK 20/25 20/25 20/25 20/25
* Difference from control statistically significant by paired t-test
(p 0.o5).
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Appendix Table 19
EFFECTS OF INTERMITTENT OXYGEN EXPOSURE AT 2.0 ATA
ON PULMONARY FUNCTION IN MAN
30:30 OXYGEN:NORMOXIC SEQUENCE
PRE POST POST- PRE POST POST-
EXP EXP PRE a EXP EXP PRE
Slow Vital Capacity
(L)
Inspiratory Capacity
(L)
N 6 6 6 6 6 6
MEAN 5.35 5.02 -0.34* 3.43 2.91 -0.52*
SD 0.96 0.85 0.32 0.59 0.42 0.27
SEM 0.39 0.35 0.13 0.24 0.17 0.Ii
Expiratory Reserve Volume
(L)
Total Lung Capacity
(L)
N 6 6 6 6 6 6
MEAN 1.92 2.09 0.17 6.27 6.23 -0.04
SD 0.43 0.47 0.26 1.13 1.09 0.23
SEM 0.18 0.19 0.ii 0.46 0.44 0.i0
CO Diffusing Capacity
(ml/CO/mm Hg/min)
Density Dependence of Flow
(% _ _maXso)
N 6 6 6 6 6 6
MEAN 34.7 33.1 -1.7" 50.6 45.2 -5.5
SD 7.0 6.8 i.i 10.9 36.3 27.5
SEM 2.8 2.8 0.4 4.5 14.8 11.2
N
MEAN
SD
SEM
Airway Resistance
(cm Hz0/L/sec)
Specifc Lung Compliance
(L/cm H20/L)
6 6 6 6 6 6
2.65 2.45 -0.20 0.116 0.089 -0.027*
0.74 0.60 0.33 0.032 0.030 0.011
0.30 0.30 0.13 0.013 0.012 0.004
Difference from control statistically significant by paired
t-test (p _ 0.05).
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Appendix Table 21
EFFECTS OF INTERMITTENT OXYGEN EXPOSURE AT 2.0 ATA
ON RESPIRATORY AND SKELETAL MUSCLE STRENGTH
30:30 OXYGEN:NORMOXIC SEQUENCE
PRE POST POST- PRE POST
EXP EXP PRE a EXP EXP
POST-
PRE
Maximum Inspiratory Pressure (cm Hz0)
At Residual Volume At Functional Residual
Capacity
N 6 6 6 6
MEAN 146.5 127.0 -19.5 119.4
SD 12.2 22.2 30.0 21.9
SEM 5.0 9.1 12.3 9.0
6 6
115.4 -4.0
22.4 23.2
9.2 9.5
Maximum Expiratory Pressure (cm H20)
At Total Lung Capacity At Functional Residual
Capacity
N 6 6 6 6 6 6
MEAN 137.5 113.1 -24.5 131.6 116.3 -15.3
SD 39.3 26.2 36.1 29.4 35.6 21.3
SEM 16.0 10.7 14.7 12.0 14.5 8.7
Maximum Handgrip
Strength (Kg)
Duration for 80% Maximum
Handgrip (Sec)
N 6 6 6 6 6 6
MEAN 50.3 46.7 -3.6 42.7 35.3 -7.4
SD 8.2 7.4 4.0 24.2 11.4 21.6
SEM 3.3 3.0 1.6 9.9 4.6 8.8
Difference from control signficantly significant by paired
t-test (p S 0.05).
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